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ABSTRACT

Entamoeba histolytica is an amoebic parasite that infects an estimated 90 million people
worldwide and causes approximately 100,000 deaths per year. As the causative agent of amoebic
dysentery, this food- and water-borne pathogen represents a significant public health burden
worldwide, particularly in areas with poor sanitation. While treatments for amoebiasis exist, they
are often limited in their effectiveness. Thus, efforts to better understand the biology and
physiology of this organism are vital to the development of novel treatments for this disease.
E. histolytica lacks the enzymes for many common metabolic pathways such as the citric
acid cycle and oxidative phosphorylation and relies primarily on a pyrophosphate (PPi)dependent glycolytic pathway for ATP production. This microaerophilic organism produces
ethanol and acetate as the primary products of glucose metabolism. These metabolites are
produced in an extended glycolytic pathway in which pyruvate is converted to acetyl-CoA,
which is then converted to ethanol and acetate by the bifunctional alcohol/aldehyde
dehydrogenase (ADHE) and ADP-forming acetyl-CoA synthetase (ACD), respectively.
The acetate kinase (ACK) of E. histolytica catalyzes the conversion of acetyl phosphate
into acetate and acts preferentially in the acetate-forming direction. Uniquely, this enzyme
produces PPi instead of ATP, raising the possibility that it may make a substantial contribution to
acetate and PPi levels. However, the source of its acetyl phosphate substrate is unknown.
Ethanol production by ADHE consumes more NADH than is produced by glycolysis,
creating an imbalance. The polyol pathway has been investigated in humans for its role as an
alternative glucose metabolism pathway that results in the production of fructose and NADH.
This pathway consists of two reactions. In the first reaction, aldose reductase (AR) catalyzes the
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NADPH-dependent conversion of a sugar into its corresponding sugar alcohol. In the second
reaction, sorbitol dehydrogenase (SDH) catalyzes the NAD-dependent conversion of sorbitol
into fructose, generating NADH. The presence of such a pathway in E. histolytica would
potentially balance the NAD+/NADH requirement and produce fructose, which would re-enter
glycolysis.
We investigated aldose reductase for its role in a potential polyol pathway in E.
histolytica. We biochemically characterized two recombinant AR isozymes, termed EhAR1 and
EhAR3, and found them to act primarily in the sugar alcohol-forming reaction direction. These
isozymes demonstrate activity with a broad range of sugar and sugar alcohol substrates, with
glyceraldehyde being the primary substrate. EhAR1 and EhAR3 display different oligomeric
states as a monomer and a dimer, respectively, and an aldose reductase knockdown had no effect
on cells grown in various concentrations of glucose. We also attempted to detect sorbitol
dehydrogenase activity in cell extracts, but the inability to do so suggests that E. histolytica lacks
a functional polyol pathway. This indicates that aldose reductase serves a different metabolic role
as a glyceraldehyde reductase.
To investigate the contribution that acetate kinase makes towards acetate and PPi
production, we measured concentrations of several extracellular and intracellular metabolites in
an ACK knockdown strain. Acetate and ethanol levels were not affected; similarly, the ACK
knockdown did not affect cell growth in various glucose concentrations. However, acetyl-CoA
levels and the NAD+/NADH ratio were significantly elevated. Furthermore, we demonstrated
that glyceraldehyde 3-phosphate dehydrogenase (GAPDH) catalyzes the ACK-dependent
conversion of acetaldehyde to acetyl phosphate, revealing a source of substrate for acetate
kinase.
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Here, we have investigated two pathways for their potential roles in glucose metabolism
and maintenance of the NAD+/NADH balance needed for completion of glycolysis. We have
demonstrated that ACK fulfills this role by partitioning acetyl-CoA between ethanol and acetate
production in the extended glycolytic pathway. AR, on the other hand, appears not to be involved
in the production of NADH but rather in the reduction of aldehydes, which may provide a
protective mechanism for E. histolytica against these reactive species found in the human
intestinal tract.
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CHAPTER I
LITERATURE REVIEW

Introduction
Entamoeba histolytica is a protozoan parasite that is the causative agent of amebiasis in
humans (Fotedar et al., 2007). Because E. histolytica is a food- and water-borne contaminant that
enters its human host via the fecal-oral route, it is most prevalent in areas with poor sanitation,
making it a significant public health burden on developing nations (World Health Organization,
2007). While metronidazole is used as the primary treatment for amebic infection, it comes with
several disadvantages including side effects and poor efficacy (Pittman & Pittman, 1974; Powell,
MacLeod, Wilmot, & Elsdon-Dew, 1966). The development of new treatments for amebiasis is
desirable, but first a greater understanding of the organism’s physiology and metabolism is
needed.
The purpose of this review is to provide an overview of the unique physiology of E.
histolytica and the global health burden it presents. The two major topics are acetate metabolism,
with an emphasis on acetate kinase, and the biochemical characteristics and physiological
significance of aldose reductase.

Entamoeba histolytica
Entamoeba histolytica is a microaerophilic, protozoan parasite that is the causative agent
of amebiasis in humans (Fotedar et al., 2007). This parasite causes symptomatic infection in
approximately 50-90 million people each year around the world, with approximately 100,000 of
those affected dying from liver abscesses (World Health Organization, 2007). While E.
1

histolytica can be found and potentially cause disease around the world, the vast majority of
infections are found in developing nations where the quality of sanitation is poor, making it a
large public health burden on developing nations (World Health Organization, 2007). E.
histolytica is classified by the National Institute of Allergy and Infectious Diseases (NIAID) as a
Category B Priority Pathogen with bioterrorism potential due to its low infectious dose, moderate
morbidity rate, ability to be genetically modified, and ability to be disseminated through food
and water supplies. (Shirley, Farr, Watanabe, & Moonah, 2018).

Life cycle and disease
Entamoeba histolytica exists in two life stages: the dormant, infectious, non-proliferating
cyst stage, and the motile, proliferating trophozoite stage (Lohia, 2003). Outside of the host, the
amoebae exist as cysts, which range in size from 10-16µm and contain four nuclei; furthermore,
cysts have a chitinous cell wall that allows them to survive. (Lohia, 2003). Once cysts are
ingested via food or water contaminated with fecal matter, they travel through the digestive tract
of the host, beginning excystation in the small intestine. Here the parasite transitions to the
trophozoite form and moves on to the large intestine, where it colonizes in the host (Figure 1.1).
Trophozoites range in size from 20-40µm, generally have a single nucleus, and move with the
use of a pseudopodium (Lohia, 2003). While the encystation and excystation events are of great
interest to researchers hoping to better understand this dangerous parasite, the environmental
conditions that trigger these processes are currently unknown.
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Figure 1.1. Entamoeba histolytica life cycle. 1) E. histolytica cysts and trophozoites are
excreted in the stool of infected individuals. 2) Infection occurs when mature cysts are ingested.
3) Excystation occurs in the small intestine, where 4) the newly released trophozoites travel to
and colonize in the colon (A). The trophozoites multiply and either remain confined to the
intestinal lumen, causing noninvasive infection in asymptomatic carriers, or invade the intestinal
mucosa (B) and cause symptomatic amebiasis. Infection can also occur in sites outside the
intestine such as the liver, lungs, and brain (C). 5) Some trophozoites undergo encystation and
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are excreted from the host to infect new individuals. Figure obtained and modified from the CDC
website (Centers for Disease Control and Prevention, 2019).
Upon colonization, the trophozoites either remain in the gut lumen and feed on enteric
bacteria by phagocytosis or may invade the host to cause pathogenic amebiasis (Centers for
Disease Control and Prevention, 2019). While only 10% of infections are symptomatic, the
remaining 90% of infected individuals carry and shed cysts, further spreading the disease
(Centers for Disease Control and Prevention, 2019). Symptomatic cases of E. histolytica
infection fall within two categories. In the less severe cases, the trophozoites invade the host’s
intestinal mucosa, causing amebic colitis and resulting in severe diarrhea that can last several
weeks (Centers for Disease Control and Prevention, 2019). In the more severe cases, the
trophozoites invade the host’s bloodstream and infect the liver, brain, and lungs, a condition
which often proves fatal if left untreated (Centers for Disease Control and Prevention, 2019).
E. histolytica often draws comparisons to Giardia lamblia and Cryptosporidium parvum,
two common intestinal parasites that also cause persistent diarrhea in humans (Hemphill, Müller,
& Müller, 2019). All three parasites colonize the digestive tract in humans; however, while E.
histolytica colonizes the colon, G. lamblia and C. parvum colonize farther up the intestinal tract
in the duodenum, jejunum, and ileum (Hemphill et al., 2019). These protozoan pathogens also
follow an oral-fecal mode of transmission as for E. histolytica (Hemphill et al., 2019). In the case
of E. histolytica and G. lamblia, infection occurs once the cysts transition to the trophozoite stage
(Hemphill et al., 2019). In C. parvum, sporozoites contained in the oocysts cause infection by
invading intestinal epithelial cells and undergoing either asexual or sexual proliferation
(Hemphill et al., 2019).
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Proper detection and identification of E. histolytica is vital to administering appropriate
treatments to affected individuals. Traditionally, microscopic analysis of stool samples has been
the primary method used to diagnose amebic infection; however, the major limitation of this
method is that it cannot distinguish infection by the pathogenic E. histolytica from infection by
nonpathogenic E. dispar and E. moshkovskii, commensal intestinal parasites that are
morphologically identical to E. histolytica (A. Singh, Houpt, & Petri, 2009). Newer techniques
utilizing enzyme-linked immunosorbent assay (ELISA) and stool polymerase chain reaction
(PCR) have shown greater sensitivity and specificity and are now the diagnostic methods of
choice; unfortunately, the high cost often prohibits the use of this technique in the areas where
amebiasis is endemic, as the quality of healthcare provided in these areas is usually limited by
economic constraints (Ankri & Nagaraja, 2019).
A vaccine against infection by E. histolytica does not yet exist. Infected individuals are
primarily treated with metronidazole, a synthetic antibiotic developed in 1959 for use against
trichomoniasis but which has since been shown to be effective against a variety of infections in
humans such as amebiasis, giardiasis, and Clostridium difficile colitis. (Hernández Ceruelos,
Romero-Quezada, Ruvalcaba Ledezma, & López Contreras, 2019). Metronidazole treatment is
not without its issues, however. Side effects including nausea, vomiting, dry mouth, and
headache have been reported (Powell et al., 1966). Additionally, recurrence of amebic liver
abscess after metronidazole treatment has been reported, suggesting that the drug is not
completely efficacious (Pittman & Pittman, 1974). Since metronidazole is generally absorbed in
the small intestine and little of the drug reaches the lumen of the colon, luminal agents should be
administered following metronidazole treatment to kill any remaining parasites in the intestine
(Pritt & Graham Clark, 2008). Some clinical strains of E. histolytica have been shown to be
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partially resistant to metronidazole, compelling researchers to search for alternative treatments
(Bansal et al., 2004). Several other drugs including secnidazole, ornidazole, tinidazole, and
nitazoxanide have been assessed as showing benefit against amebic infection (Mackey-Lawrence
& Petri, 2011; Marie & Petri, 2014).
The genus Entamoeba extends well beyond the pathogenic E. histolytica, with at least 51
distinct species having been identified to date (Hooshyar, Rostamkhani, & Rezaeian, 2015). A
number of these, including E. histolytica, Entamoeba dispar, Entamoeba moshkovskii,
Entamoeba coli, Entamoeba hartmanni, Entamoeba polecki, and Entamoeba bangladeshi can be
found in the human intestinal tract, although more than 80% of these infections are caused by E.
histolytica and E. dispar (Cui, Li, Chen, & Zhang, 2019). While E. dispar is the more common
cause of intestinal infection in humans, E. histolytica presents a greater public health concern due
to the dysentery it causes. Another species infecting humans is E. gingivalis, which colonizes the
gingival pockets of human mouths (Cui et al., 2019). Captive and wild lemurs suffering from
diarrhea have been found infected with E. histolytica, but it is not known if the Entamoeba
infection was the causative agent of dysentery in these cases (Ragazzo et al., 2018).
While studies on non-human primates have been relatively few, a number of Entamoeba
species present in these populations have been described, including Entamoeba chattoni, E. coli,
E. dispar, E. hartmanni, Entamoeba nuttalli, and E. polecki (Cui et al., 2019). These species
have also been detected in other mammalian species including pigs, cattle, sheep, goats, horses,
rodents, deer, and Asian elephants (Cui et al., 2019). In addition to infecting mammals, several
species of Entamoeba have been detected in reptiles, including Entamoeba invadens, Entamoeba
terrapinae, Entamoeba insolita, Entamoeba barreti, Entamoeba testudines, and Entamoeba
ranarum, with E. invadens being the most widespread (Garćia et al., 2014). Like E. histolytica,
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E. invadens is known to be pathogenic and can cause fatal disease (Chia et al., 2009; Kojimoto et
al., 2001; Meerovitch, 1958). E. invadens is often used as a model to study encystation and
excystation, as it was previously the only Entamoeba species in which encystation can be
successfully induced in vitro in axenic culture (Avron, Stolarsky, Chayen, & Mirelman, 1986;
Garcia-Zapien, Hernandez-Gutierrez, & Mora-Galindo, 1995; Vazquezdelara-Cisneros &
Arroyo-Begovich, 1984). Recently, Wesel et al. demonstrated encystation and excystation in E.
histolytica, allowing us now to study these processes directly in the human pathogen (Wesel,
Shuman, Bastuzel, Dickerson, & Ingram-Smith, 2021).

Genome information
In 2000, the Wellcome Trust Sanger Institute and The Institute for Genomic Research
(TIGR) collaborated to launch the E. histolytica genome project (C.G. Clark et al., 2007). Using
a whole-genome shotgun approach, the genome was sequenced to achieve 12.5-fold coverage
and the assembly was published in 2005, making it the first amoeba genome to be fully sampled
(Loftus et al., 2005). The genome of E. histolytica consists of both linear chromosomes as well
as numerous plasmid-like, circular DNA molecules that are common to all strains and species of
Entamoeba (Dhar, Choudhury, Bhattacharaya, & Bhattacharya, 1995; Lioutas, Schmetz, &
Tannich, 1995). Assembly of the reference strain HM-1:IMSS yielded a genome that was
approximately 20 megabases in size, making it significantly larger than the genome of Giardia
lamblia (11.2 megabases) (Adam et al., 2013) and slightly smaller than the genomes of
Plasmodium falciparum (23 megabases) (Gardner et al., 2002) and Trypanosoma brucei (26
megabases) (Berriman et al., 2005).
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The genome is predicted to contain 8,734 protein-coding genes (Kawano-Sugaya et al.,
2020), and most of the genes consist only of a single exon; however, as many as 25% of them are
predicted to contain introns, with 6% containing two or more (Loftus et al., 2005). The genome
of E. histolytica has a low G + C content of approximately 22.4%, with the G + C content being
about 33% higher in protein-coding regions (López-Revilla & Gómez-Domínguez, 1988;
Tannich & Horstmann, 1992). The chromosomes of E. histolytica do not condense at any stage
of the cell cycle, making their quantification difficult; however, one study employing pulse-field
gel electrophoresis identified 31-35 chromosomes ranging in size from 0.3 to 2.2 megabases
each (Willhoeft & Tannich, 1999). This study also predicted that the E. histolytica genome is
generally tetraploid, a premise that was verified through analysis of the distribution of SNP
allelic frequencies across the genome (Kawano-Sugaya et al., 2020; Willhoeft & Tannich, 1999).
Recent genome analysis has revealed that ploidy may vary between strains and may be
influenced by environmental conditions; interestingly, ploidy variation does not seem to affect
gene expression (Kawano-Sugaya et al., 2020).

Energy metabolism of E. histolytica
The metabolism of E. histolytica differs significantly from that of most other eukaryotes
in that many common pathways are absent. An amitochondriate, this organism lacks many
common metabolic pathways including the tricarboxylic acid (TCA) cycle and oxidative
phosphorylation; furthermore, it lacks pathways for purine and pyrimidine biosynthesis, the
biosynthesis of most amino acids, and the pentose phosphate pathway (Anderson & Loftus,
2005; Loftus et al., 2005; Reeves, 1984). Consequently, E. histolytica is a scavenger that relies
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on substrate level phosphorylation to produce ATP and other high-energy compounds, and
glycolysis is thought to be the major pathway for ATP production (Anderson & Loftus, 2005).
As a scavenger, E. histolytica uses constitutive endocytosis to take in fluids, nutrients,
and solid components from its extracellular environment in a variety of ways (Meza & Clarke,
2004). E. histolytica trophozoites use micropinocytosis to assimilate fluids and nutrients from the
extracellular environment (Meza & Clarke, 2004). During colonization of the host’s intestinal
mucosa, phagocytosis allows trophozoites to consume bacteria and solid debris. Inhibition of
phagocytosis has been shown to result in decreased proliferation and loss of pathogenicity in E.
histolytica (Hirata et al., 2007); therefore, it is believed that the growth and virulence of this
parasite depends greatly on the interaction between bacteria in the human gut and E. histolytica
trophozoites (Sahoo et al., 2004). Furthermore, the response of an individual to infection by E.
histolytica can vary greatly depending on that individual’s microbiota composition (Bär, Phukan,
Pinheiro, & Simoes-Barbosa, 2015; Marie & Petri, 2014), which fluctuates from person to
person (Lozupone, Stombaugh, Gordon, Jansson, & Knight, 2012). Interestingly, clinical
evidence suggests that intestinal protists such as E. histolytica, Giardia duodenalis, and
Blastocystis hominus can trigger significant changes in the composition of the gut microbiota in
infected hosts which can affect the virulence of the disease (Burgess, Gilchrist, Lynn, & Petri,
2017).
Endocytosis has also been shown to be the mechanism of action behind the killing of host
cells by E. histolytica trophozoites (Ralston et al., 2014). In a process termed trogocytosis,
amoebae ingest distinct pieces of living human cells, which causes a marked increase in
intracellular calcium levels in the human cells and, eventually, their death (Ralston et al., 2014).
This process, which ends once the victim human cell is dead, also contributes to invasion of the
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intestinal tissue (Ralston et al., 2014). E. histolytica trophozoites use endocytosis not only to take
in the nutrients and solid components needed for their survival but as a necessary factor in cell
proliferation, tissue invasion, and host cell killing.
The metabolism of E. histolytica seems to have been significantly affected by gene loss
and by the assimilation of bacterial genes via lateral gene transfer; additionally, the glucose
transporters in E. histolytica are related not to other eukaryotes but to the prokaryotic
glucose/ribose porter family (Loftus et al., 2005). While E. histolytica does not possess
mitochondria, organelles known as mitosomes have been observed within the cell. Mitosomes
are the names now given to cytoplasmic, mitochondrion-related organelles that have lost the
ability to synthesize ATP (Aguilera, Barry, & Tovar, 2008). Found in numerous protozoans
living in oxygen-poor environments, mitosomes are related to mitochondria and are widely used
as models for the study of mitochondrial evolution (Tovar, Fischer, & Clark, 1999). Phylogenetic
analyses based on the small subunit ribosomal RNA genes and on two genes encoding
mitochondrial marker proteins, chaperonin 60 (Cpn60) and pyridine nucleotide transhydrogenase
(PNT), indicate that the genus Entamoeba diverged from other eukaryotes after mitochondria
had already evolved (C. Graham Clark & Roger, 1995; Sogin, 1991). Furthermore, Cpn60 has
been shown to be expressed in trophozoites and is compartmentalized in mitosomes (Tovar et al.,
1999). While the mitosome’s primary role in E. histolytica remains a mystery, there exists
evidence that mitosomes play a part in iron-sulfur cluster formation and sulfate activation
pathways (Mi-Ichi, Nozawa, Yoshida, Tozawa, & Nozaki, 2015; Mi-ichi, Yousuf, NakadaTsukui, & Nozaki, 2009; Nývltová et al., 2015).
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Glycolysis
Glycolysis, an ancient metabolic pathway present in the vast majority of organisms alive
today, is the process by which glucose is broken down into two molecules of pyruvate, releasing
energy for use by a cell. Found in both aerobic and anaerobic organisms, glycolysis is an
important and conserved pathway for energy metabolism, and this is no different in E.
histolytica; there are, however, a few dissimilarities in the glycolytic pathway of this parasite that
separate it from that of typical eukaryotes.
In the glycolytic pathway, several notable enzyme substitutions take place (see Figures
1.2 and 1.3). Whereas eukaryotes generally utilize an ATP-dependent phosphofructokinase
(PFK; EC 2.7.1.11) to catalyze the conversion of fructose-6-phosphate to fructose-1, 6bisphosphate, E. histolytica utilizes a PFK that is PPi-dependent (PPi-PFK; EC 2.7.1.90) (Reeves,
1974). In the last step of glycolysis, the pyruvate kinase (PK; EC 2.7.1.40) that catalyzes the
production of pyruvate from phosphoenolpyruvate is replaced by a PPi-dependent pyruvate
phosphate dikinase (PPDK; EC 2.7.9.1) (Reeves, 1968). PPDK shares a similarity with PK in
that it also produces ATP, albeit by using AMP instead of ADP as the phosphoryl acceptor.
Notably, PPi-PFK and PPDK are not allosterically regulated as are their conventional eukaryotic
counterparts (Saavedra, Encalada, Pineda, Jasso-Chávez, & Moreno-Sánchez, 2005).
In typical eukaryotes, glycolysis takes place in the cytosol, and the pyruvate produced by
the breakdown of glucose is imported into mitochondria, where it is then converted into acetylCoA, CO2, and NADH by the pyruvate dehydrogenase complex (PDC; EC 1.2.4.1); however, in
E. histolytica, PDC is replaced by pyruvate:ferredoxin oxidoreductase (PFOR; EC 1.2.7.1),
which transfers the electrons produced during pyruvate oxidation to ferredoxin (see Figure 1.3)
(Reeves, Warren, Susskind, & Lo, 1977). Because E. histolytica possesses mitosomes instead of
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mitochondria, the conversion of pyruvate into acetyl-CoA by PFOR takes place in the cytosol
(Reeves et al., 1977). In aerobic conditions, PFOR experiences reduced activity (Reeves et al.,
1977), and the enzyme is inhibited in amoebae subjected to oxidative stress conditions (Pineda et
al., 2010; Ramos-Martínez et al., 2009). The role of PFOR is also of clinical significance, as the
reduced ferredoxin produced in the pyruvate oxidation reaction is the main electron donor for
metronidazole (Upcroft & Upcroft, 2001).

Figure 1.2. Comparison of glycolytic pathways. Left: the glycolytic pathway in typical
eukaryotes. Right: the glycolytic pathway of the protozoan parasite E. histolytica. PFK:
12

phosphofructokinase; PK: pyruvate kinase; PPi-PFK: PPi-dependent phosphofructokinase;
PPDK: PPi-dependent pyruvate phosphate dikinase. Dashed arrows represent several enzymatic
reactions not shown. The reaction diagrams downstream of fructose-1,6-bisphosphate display
one of two duplicate pathways formed from the breakdown of this substrate.

Figure 1.3. The extended glycolytic pathway of E. histolytica. PFOR: pyruvate:ferredoxin
oxidoreductase; ACD: acetyl-CoA synthetase (ADP-forming); ADHE: bifunctional
alcohol/aldehyde dehydrogenase.

Once PFOR has oxidized pyruvate, the resulting acetyl-CoA does not proceed to the
citric acid cycle and on to oxidative phosphorylation, which are absent in E. histolytica. Instead,
it follows one of two paths in an extension of the glycolytic pathway (Bragg & Reeves, 1962). It
may be converted to acetate through the action of ADP-forming acetyl-CoA synthetase (ACD;
EC 6.2.1.13), producing ATP in the process, or it may be converted to acetaldehyde and then to
ethanol through the action of a bifunctional alcohol-aldehyde dehydrogenase (ADHE; EC
1.1.1.1), regenerating reducing power in the form of NAD+ (Bragg & Reeves, 1962; Lo &
13

Reeves, 1978; Reeves et al., 1977). The ultimate products formed by the completion of
glycolysis are ethanol, acetate, CO2, and H2, but the environment in which E. histolytica exists
greatly impacts preferential formation of one product over another: under anaerobic growth
conditions, production of ethanol is favored over acetate at a ratio of 2:1, whereas this ratio shifts
to 1:2 in an aerobic environment (Montalvo, Reeves, & Warren, 1971). Experimental evidence
suggests that inhibition of ADHE by reactive oxygen species (ROS), which are generated in cells
that suffer from oxidative stress as a result of exposure to an aerobic environment, is the cause of
the acetate shift (Pineda et al., 2015).

Amino acid use in energy metabolism
While carbohydrate catabolism is an efficient means of providing energy for E.
histolytica, the parasite must also have a means of sustaining itself when it encounters low-sugar
environments. The means to assimilate and utilize amino acids as an energy substrate has been
observed in other protozoan parasites including trichomonads and Giardia (Lockwood &
Coombs, 1991; Schofield, Edwards, Thompson, Reynoldson, & Lymbery, 1994) and so the
question has been raised if E. histolytica possesses this capacity as well. Previous works have
suggested that amino acid degradation can contribute to ATP supply in E. histolytica (C.G. Clark
et al., 2007; Zuo & Coombs, 1995).
Threonine and methionine are strong candidates for use as energy substrates in lowglucose environments. E. histolytica readily takes up both amino acids (Zuo & Coombs, 1995),
and has three putative threonine dehydratase genes (Anderson & Loftus, 2005). This enzyme
converts L-threonine to 2-oxybutanoate, and two isotypes have been detected and characterized
(Husain, Jeelani, Sato, Ali, & Nozaki, 2010). The 2-oxobutanoate product can then be converted
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to propionyl-CoA by PFOR. Propionyl-CoA has been shown to serve as a substrate for ACD and
used to generate ATP (Reeves et al., 1977; Samarawickrema, Brown, Upcroft, Thammapalerd, &
Upcroft, 1997). Like L-threonine, L-methionine can be converted to 2-oxybutanoate for use by
PFOR or for ATP production. The enzyme catalyzing this reaction is methionine γ-lyase
(MGL;EC 4.4.1.11), for which two genes were identified in E. histolytica (Anderson & Loftus,
2005). E. histolytica has two isozymes of MGL, which it uses to degrade the sulfur-containing
amino acids L-methionine, L-methylcysteine, and L-cysteine (Sato, Yamagata, Harada, &
Nozaki, 2008; Tokoro, Asai, Kobayashi, Takeuchi, & Nozaki, 2003).
Leucine and serine also show the potential to be used in energy metabolism. E. histolytica
takes up L-leucine from growth medium with and without glucose (Zuo & Coombs, 1995), and
leucine serves as an electron acceptor in T. vaginalis, where an aminotransferase converts
leucine to α-ketoisocaproate (Lowe & Rowe, 1986). This acid is then converted to propionate,
among other end products, in an energy-generating pathway (Lockwood & Coombs, 1991; Zuo
& Coombs, 1995). However, evidence of an aminotransferase that acts on leucine has not yet
been found in E. histolytica. The parasite has the ability to take in L-serine and use it as an
energy source, and the enzyme responsible for catalyzing the breakdown of L-serine, serine
dehydratase (EC 4.3.1.18), has been detected and characterized in E. histolytica (Husain et al.,
2010; Takeuchi, Weinbach, Gottlieb, & Diamond, 1979); however, experimental data suggests
that serine may be less effective than other amino acids at providing energy for the cell (Zuo &
Coombs, 1995).
Putative genes encoding enzymes that catalyze the degradation of aspartate, asparagine,
tryptophan, threonine, and methionine have been identified, but it is not known if E. histolytica
can use these amino acids as an energy source (Anderson & Loftus, 2005). E. histolytica takes up
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L-arginine in great quantities, particularly when glucose is lacking from the growth media (Zuo
& Coombs, 1995). This suggests that this amino acid may be one of several that can be used as
an alternative energy source in a low-glucose environment. Arginine is used to generate ATP
through the arginine dehydrolase pathway in Giardia lamblia and Trichomonas vaginalis
(Linstead & Cranshaw, 1983; Schofield, Costello, Edwards, & O’sullivan, 1990); however, E.
histolytica does not appear to possess this pathway, leaving the mechanism by which the
organism uses arginine for energy metabolism a mystery (Zuo & Coombs, 1995).
Because E. histolytica possesses the ability to synthesize de novo only two amino acids,
L-serine and L-cysteine, it relies heavily on phagocytosis of compounds found in the human gut
to provide raw materials for synthesis of ATP and many other metabolites (Loftus et al., 2005).
While the parasite has been observed to take up several extracellular amino acids, one study
examining trophozoites incubated for two hours in phosphate-buffered saline (PBS) with and
without added amino acids concluded that ATP generation in the cells is not significantly
affected by amino acid utilization (Pineda et al., 2015). Nevertheless, much work remains to be
done to determine if amino acids represent viable, alternative substrates for energy production.

Acetate metabolism
The short-chain fatty acid (SCFA) acetate is commonly produced in many organisms.
Depending on its metabolic needs, a cell can either produce and excrete acetate or assimilate and
catabolize it in a process termed the “acetate switch” (Wolfe, 2005). The acetate switch is an
important mechanism to allow organisms to produce ATP and regenerate NAD+ and CoA
needed in metabolic reactions (Wolfe, 2005). For bacteria, this mechanism allows growth to
proceed in both nutrient-rich environments, when carbon sources exist in abundance, and in
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nutrient-poor environments, when external acetate must be assimilated for energy metabolism
(Wolfe, 2005). In eukaryotes, the acetate switch enables metabolic intermediates to move
between intracellular compartments (Wolfe, 2005). Acetogenesis occurs in the absence of the
TCA cycle or when a cell is unable to process all of the carbon it is taking in, leading many to
consider it to be simply the result of “overflow” metabolism (Wolfe, 2005).
Acetate is a significant redistributable carbon source in humans, and acetate production
within the body occurs both systemically and locally (Moffett, Puthillathu, Vengilote, Jaworski,
& Namboodiri, 2020; E. Pouteau et al., 1996; Etienne Pouteau, Meirim, Métairon, & Fay, 2001;
Etienne Pouteau, Nguyen, Ballevre, & Krempf, 2003). Systemic production takes place in the
tissues and acetate and is exported, and acetate and other SCFAs are found in greater amounts in
certain areas of the body than others (Moffett et al., 2020). Specifically, acetate is concentrated
mainly in the liver, where it can be exported via the bloodstream to peripheral tissues during
periods of nutritional stress, and in the intestines, where the fermentation of indigestible
carbohydrates by commensal gut bacteria produces acetate as one of its major end products
(Arpaia & Rudensky, 2014; Horibata, Ando, Itoh, & Sugimoto, 2013; Jaworski, Namboodiri, &
Moffett, 2016). Within the intestines, the colon shows the highest concentration of acetate, with
SCFAs making up over 60% of the anions there (Wolfe, 2005). Acetate, propionate, and butyrate
are the three most prevalent SCFAs in the gut and are present in a molar mass ratio of 57:22:21,
respectively (Cummings, Pomare, Branch, Naylor, & MacFarlane, 1987). SCFAs are readily
absorbed by the colonic mucosa, with less than 5% passing through the lower intestinal tract and
exiting the body in fecal matter (Cummings et al., 1987; Topping & Clifton, 2001). These
SCFAs represent the primary energy source for cells in the colon, liver, adipose tissue, and
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muscle (Macfarlane, McBain, & Macfarlane, 1997; Mackie, Sghir, & Gaskins, 1999; McNeil,
1984; Mortensen & Clausen, 1996; Topping & Clifton, 2001).
While insoluble fiber is thought to make the largest contribution to the acetate produced
by intestinal microbiota, other dietary sources of acetate include cheese, processed meats, and
ethanol (Bose, Ramesh, & Locasale, 2019). Interestingly, ethanol consumption and metabolism
in the liver may provide a larger source of acetate than previously thought. While baseline
acetate concentrations in human plasma generally stay in the range of 50-200 µM, one serving of
alcohol contributes to approximately 100 calories of acetate, and alcohol ingestion has been
shown result in sustained elevations of plasma acetate concentrations above 0.5 mM (Israel,
Orrego, & Carmichael, 1994; Nuutinen, Lindros, Hekali, & Salaspuro, 1985).
Locally, acetate is derived endogenously from internal metabolism and turnover, as all
cells produce acetate as a result of deacetylation reactions (Moffett et al., 2020). Acetate can also
be produced locally from the hydrolysis of acetyl-CoA produced by fatty acid β-oxidation
(Moffett et al., 2020). Pouteau et al. demonstrated experimentally that the largest contribution of
acetate in the human body comes from endogenous sources (E. Pouteau et al., 1996; Etienne
Pouteau et al., 2001, 2003).
One of the most important functions of acetate in humans is to sustain the intracellular
acetyl-CoA supply, and dysregulation of acetate metabolism has been implicated in several
diseases including cancer, obesity, and acute alcoholic hepatitis (Kendrick et al., 2010; Perry et
al., 2016; Schug, Vande Voorde, & Gottlieb, 2016). Moreover, the effect of acetate metabolism
on autonomic nervous system activation and the resulting systemic physiological manifestations
is a growing area of interest. Often called the “second brain,” the gut microbiome and host share
a variety of interactions via immune, humoral, endocrine, and neural pathways. This
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communication has been shown to make a significant contribution to insulin resistance and
metabolic syndrome, two key causes of obesity (Dinan & Cryan, 2017). In mice and rats altered
to have higher-than-normal plasma acetate concentrations, activation of the parasympathetic
nervous system was observed and was associated with increased pancreatic β-cell activity,
glucose-stimulated insulin secretion (GSIS), hyperphagia, and obesity (Perry et al., 2016). These
results suggest that, in humans, microbial acetate production may be able to influence brain
function and behavior (Perry et al., 2016).

Acetate metabolism in bacteria
Acetate metabolism has been studied extensively in bacteria, particularly in E. coli, and
the acetate switch mechanism is widespread in prokaryotes (Wolfe, 2005). In the presence of
abundant nutrients, bacteria generally experience rapid growth and produce and excrete acetate;
in limited-nutrient environments, though, bacteria have been shown to assimilate and use acetate
as an alternative carbon source (Wolfe, 2005).
In E. coli, acetate assimilation is catalyzed by acetate:CoA ligase, now known as AMPforming acetyl-CoA synthetase (ACS; EC 6.2.1.1). ACS converts acetate and ATP to acetyl-CoA
and AMP (Eq. 1) (P. Berg, 1956; Chou & Lipmann, 1952). In vivo, this reaction proceeds only in
the acetyl-CoA-forming direction (Brown, Jones-Mortimer, & Kornberg, 1977; Kumari, Tishel,
Eisenbach, & Wolfe, 1995). This is not to be confused with ACD, also called acetate thiokinase,
which catalyzes the conversion of acetyl-CoA and ADP to acetate and ATP (Eq. 2) (Tielens, van
Grinsven, Henze, van Hellemond, & Martin, 2010).
Eq. 1: ACS

acetate + CoA + ATP → acetyl-CoA + AMP + PPi

Eq. 2: ACD

acetyl-CoA + ADP + Pi ↔ acetate + ATP + CoA
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In E. coli, the decarboxylation of pyruvate into acetyl-CoA must occur first for the cell to
excrete acetate. Under aerobic conditions, this process occurs oxidatively and is catalyzed by the
PDC, generating two additional NADH per glucose (Eq. 3) (Hansen & Henning, 1966). Under
anaerobic conditions, the cells instead decarboxylate pyruvate to acetyl-CoA and formate via
pyruvate formate-lyase (PFL; EC 2.3.1.54) in a nonoxidative reaction (Eq. 4) (Knappe & Sawers,
1990).
Eq. 3: PDC

Pyruvate + NAD+ + CoA → acetyl-CoA + NADH + CO2

Eq. 4: PFL

Pyruvate + CoA ↔ acetyl-CoA + formate

In E. coli, the acetyl-CoA produced by the PDC and PFL reactions is then either
converted to ethanol via alcohol dehydrogenase (ADHE), which does not generate ATP but does
regenerate reducing power in the form of two molecules of NAD+, or to acetate, which generates
ATP (El-Mansi & Holms, 1989). The cell adjusts the ratio in which it excretes acetate and
ethanol to balance its energy and NAD+ regeneration needs (Wolfe, 2005). The conversion of
excess acetyl-CoA to acetate is catalyzed by phosphotransacetylase (PTA; EC 2.7.2.1)
(Matsuyama, Yamamoto-Otake, Hewitt, MacGillivray, & Nakano, 1994) and acetate kinase
(ACK; EC 2.3.1.8) (Lee, Makino, Shinagawa, & Nakata, 1990). PTA catalyzes the reversible
conversion of acetyl-CoA and inorganic phosphate (Pi) to acetyl phosphate and CoA (Eq. 5), and
then ACK catalyzes the reversible conversion of acetyl phosphate and ADP to acetate and ATP
(Eq. 6) (Rose, Grunberg-Manago, Korey, & Ochoa, 1954). During the exponential growth phase,
the PTA-ACK pathway is the primary acetate-producing pathway (Dittrich, Bennett, & San,
2005). This pathway also allows acetate to be used as an alternative carbon source when the cell
exists in high acetate conditions (El-Mansi & Holms, 1989).
Eq. 5: PTA

Acetyl-CoA + Pi ↔ acetyl phosphate + CoA
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Eq. 6: ACK

Acetyl phosphate + ADP ↔ acetate + ATP

Acetate can also be excreted through the action of pyruvate oxidase (POXB; EC 1.2.5.1),
which catalyzes the oxidative conversion of pyruvate directly to acetate and produces carbon
dioxide and flavin adenine dinucleotide (FAD) as byproducts (Eq. 7) (B. L. Bertagnolli & Hager,
1991; Byron L. Bertagnolli & Hager, 1993; Gennis & Hager, 1976). Evidence suggests that
POXB acts to provide the cell with energy and acetyl groups during the cell’s stationary phase
(Chang, Wang, & Cronan, 1994), where it is the dominant acetate-producing pathway (Dittrich
et al., 2005); the POXB pathway also contributes substantially to aerobic growth efficiency
(Abdel-Hamid, Attwood, & Guest, 2001).
Eq. 7: POXB

Pyruvate + ubiquinone + H2O → acetate + CO2 + ubiquinol

The acetyl phosphate needed as a substrate for the ACK reaction can be produced from
several different reactions in other organisms (Taniai et al., 2008). An alternative form of
pyruvate oxidase (POX-AP; EC 1.2.3.3) has been identified in certain lactobacilli, where it
converts pyruvate to acetyl phosphate instead of acetate (Eq. 8) (Williams & Hager, 1961;
Wolfe, 2005). In fungi and lactic acid bacteria, acetyl phosphate can be generated from xylulose
5-phosphate or fructose 6-phosphate through the action of xylulose 5-phosphate/fructose 6phosphate phosphoketolase (XFP; EC 4.1.2.9, EC 4.1.2.22), which cleaves X5P/F6P into acetyl
phosphate and glyceraldehyde-3-phosphate (G3P)/erythose-4-phosphate (E4P) (Eq. 9) (Jeffries,
1983; Meile, Rohr, Geissmann, Herensperger, & Teuber, 2001; Wolfe, 2005). The XFP enzyme
has been identified in several organisms such as Acetobacter xylinum, Butyrivibrio fibrisolvens,
Fibrobacter succinogenes and Fibrobacter intestinalis (Posthuma et al., 2002; Wolfe, 2005). In
some Gram-positive bacteria and Proteobacteria, sulfoacetaldehyde acetyltransferase (XSC; EC
2.3.3.15) desulfonates sulfoacetaldehyde, producing acetyl phosphate and sulfite (Eq. 10)
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(Brüggemann, Denger, Cook, & Ruff, 2004; Denger, Ruff, Schleheck, & Cook, 2004; Ruff,
Denger, & Cook, 2003; Wolfe, 2005). Acetyl phosphate can also be produced in certain strictly
anaerobic Gram-positive bacteria from glycine (Gly), inorganic phosphate (Pi), and thioredoxin
(Trx) in a reaction catalyzed by glycine reductase (GR; EC 1.21.4.2) (Eq. 11). Here, the products
are acetyl phosphate (AcP), ammonia, thioredoxin sulfite (TrxS), and water (Wolfe, 2005).
Eq. 8: POX-AP

Pyruvate + O2 + Pi → acetyl phosphate + CO2 + H2O2

Eq. 9: XFP

X5P/F6P + Pi → acetyl phosphate + H2O + G3P/E4P

Eq. 10: XSC

Sulfoacetaldehyde + Pi → acetyl phosphate + sulfite

Eq; 11: GR

Gly + Pi + Trx → AcP + NH3 + TrxS + H2O

Acetate metabolism in archaea
Some halophilic archaea such as Halococcus saccharolyticus, Haloferax volcanii, and
Halorubrum saccharovorum possess the same “acetate switch” mechanism as found in E. coli,
excreting acetate during exponential growth and metabolizing both glucose and acetate as they
enter stationary phase; however, they differ from E. coli in that they generally do not possess the
ACK-PTA pathway, which has thus far only been identified in the genus Methanosarcina (Ferry,
1997). Instead, these archaea catalyze acetate dissimilation using ACD (Bräsen & Schönheit,
2001; Wolfe, 2005). Schäfer and Schönheit published the first observation of ACD activity in the
thermophilic archaeon Pyrococcus furiosus (Schäfer & Schönheit, 1991), later noting that the
enzyme’s major function seems to be to conserve energy during sugar metabolism (Schönheit &
Schäfer, 1995). ACD has been identified in a number of other archaea including
Desulfurococcus amylolyticus, Hyperthermus butylicus, Thermococcus celer, Pyrococcus
woesei, and Halobacterium saccharovorum, all of which lack both PTA and ACK (Schäfer,
Selig, & Schönheit, 1993).
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Of interest, report of the first observation of the acetate switch in a methanogenic
autotroph was published in 2020. The organism, Methanococcus maripaludis S2, excreted
acetate in the early growth phase and assimilated it in the late growth phase when grown in
minimal medium with CO2 as the sole carbon source and either ammonium or dinitrogen as the
sole nitrogen source (Vo, Goyal, Karimi, & Kraft, 2020).

Acetate metabolism in eukaryotes
The ability to utilize acetate in the production of acetyl-CoA is important to eukaryotes,
as acetyl-CoA plays several important roles within the cell. A key intermediate in central
metabolic processes, including glycolysis and pyruvate oxidation as well as β-oxidation of fatty
acids, acetyl-CoA also allosterically regulates enzymatic reactions and mediates protein
acetylation on lysine residues (Choudhary, Weinert, Nishida, Verdin, & Mann, 2014). In the
nucleus, acetyl-CoA is essential for histone acetylation reactions involved in chromatin
remodeling and DNA repair (Campbell & Wellen, 2018; Sivanand, Viney, & Wellen, 2018).
Acetyl-CoA has also been proposed to act as a second messenger by affecting numerous
metabolic pathways as its concentration changes (Pietrocola, Galluzzi, Bravo-San Pedro, Madeo,
& Kroemer, 2015).
Acetyl-CoA is a large, hydrophilic molecule with a high-energy thioester bond between
the acetyl group and CoA that makes the transfer of the acetate group energetically favorable in
enzymatic reactions; however, due to its size, acetyl-CoA requires assistance from transporters to
cross membranes (Moffett et al., 2020). In many organisms, acetyl-CoA is used to generate ATP
in the TCA cycle through oxidation of the acetyl moiety (Walsh, Tu, & Tang, 2018). Because it
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possesses an energy-rich thioester bond, acetyl-CoA is able to transfer its acetyl moiety to a
variety of acceptor molecules, including amino acid residues in proteins (L. Shi & Tu, 2015).
Eukaryotes produce acetyl-CoA during energy metabolism by three main routes:
pyruvate catabolism, β-oxidation of fatty acids, and ketogenic amino acid catabolism (Tielens et
al., 2010). Pyruvate is formed via the catabolism of carbohydrates and the gluconeogenic amino
acids alanine, glycine, cysteine, serine, and tryptophan. Pyruvate can then be used to synthesize
acetyl-CoA by way of the PDC (Eq. 3), pyruvate:ferredoxin oxidoreductase (also called PFO or
pyruvate synthase; EC 1.2.7.1; Eq. 16) (Müller, 2003), or pyruvate:NADP+ oxidoreductase (also
called PNO or pyruvate dehydrogenase (NADP+); EC 1.2.1.51; Eq. 17) (Lantsman, Tan, Morada,
& Yarlett, 2008). During the β-oxidation of fatty acids, acetyl-CoA is produced from the reaction
of a β-ketoacyl-CoA with a molecule of free CoA, catalyzed by acetyl-CoA acyltransferase (also
called thiolase; EC 2.3.1.16). Acetyl-CoA is produced during the degradation of ketone bodies in
a two-step process: succinyl-CoA:3-ketoacid CoA-transferase (SCOT; EC 2.8.3.5) catalyzes the
activation of acetoacetate by succinyl-CoA (Eq. 12), and then thiolase splits the resulting
acetoacetyl-CoA into two molecules of acetyl-CoA (Eq. 13) (Tielens et al., 2010). Ketogenic
amino acids can be degraded to form acetyl-CoA directly without the need to produce pyruvate
first (Tielens et al., 2010).
Eq. 12: SCOT

acetoacetate + succinyl-CoA ↔ acetoacetyl-CoA + succinate

Eq. 13: Thiolase

3-oxoacyl-CoA + CoA ↔ acetyl-CoA + acyl-CoA

The primary source of acetyl-CoA in many human cell types is glucose, which is
converted to pyruvate through glycolysis. During glycolysis in typical eukaryotes, the PDC
catalyzes the oxidative decarboxylation of pyruvate to generate acetyl-CoA in the mitochondria
(Eq. 3). This acetyl-CoA can then be used with oxaloacetate (OAA) in a condensation reaction,
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catalyzed by citrate synthase (CS; EC 2.3.3.1), to produce citrate (Eq. 14), which can either
proceed to the TCA cycle or can be transported to the cytosol. Here, the enzyme ATP-citrate
lyase (ACLY; EC 2.3.3.8) catalyzes a reaction that regenerates acetyl-CoA and oxaloacetate (Eq.
15) (L. Shi & Tu, 2015). Cell nuclei may also have the ability to generate ACLY de novo, as
expression of the enzyme has been detected there (Wellen et al., 2009). Isozymes of ACS can
also catalyze the synthesis of acetyl-CoA from acetate in both the mitochondria (ACSS1) and the
cytosol (ACSS2) (Schwer, Bunkenborg, Verdin, Andersen, & Verdin, 2006; Yoshii et al., 2009).
Eq. 14: CS

Acetyl-CoA + OAA + H2O → citrate + CoA

Eq. 15: ACLY

Citrate + ADP + CoA → acetyl-CoA + OAA + ADP + Pi

PFO activity in eukaryotes was first discovered in the hydrogenosomes of trichomonads
(D. G. Lindmark & Muller, 1973), where the enzyme catalyzes the interconversion of pyruvate
and acetyl-CoA (Eq. 16). In some eukaryotes, PNO exists as an alternate form of PFO. This
enzyme, first observed in Euglena gracilis (Inui, Miyatake, Nakano, & Kitaoka, 1984),
decarboxylates pyruvate to acetyl-CoA while reducing NADP+ (Eq. 17). PNO has also been
identified in the apicomplexan pathogen Cryptosporidium parvum (Rotte, Stejskal, Zhu, Keithly,
& Martin, 2001) and a species of Blastocystis (Lantsman et al., 2008).
Eq. 16: PFO

Pyruvate + CoA + ox. ferredoxin ↔ acetyl-CoA + CO2 + red. ferredoxin

Eq. 17: PNO

Pyruvate + CoA + NADP+ ↔ acetyl-CoA + NADPH + CO2

While much more common in prokaryotes, PFL has been identified in a few eukaryotes
including species of the fungi Piromyces and Neocallimastix, obligatory amitochondriate
anaerobes that possess hydrogenosomes. This enzyme catalyzes the decarboxylation of pyruvate
to form acetyl-CoA and formate (Eq. 4) (Akhmanova et al., 1999; Gelius-Dietrich & Henze,
2004).
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Evidence of an “acetate switch” has been found in mammals (Crabtree, Gordon, &
Christie, 1990). Exogenous acetate is produced by bacterial fermentation in the colon and is
transported to the liver. There, it is converted to acetyl-CoA through the action of ACS (Buckley
& Williamson, 1977; Puchowicz et al., 1999; Scheppach, Pomare, Elia, & Cummings, 1991).
Endogenous acetate is generated within the cytosol of cells from acetyl-CoA not by way of an
acetyl phosphate intermediate, since mammals do not produce acetyl phosphate as bacteria do,
but via acetyl-CoA hydrolase (ACH; EC 3.1.2.1) (Crabtree, Souter, & Anderson, 1989). In nonruminant mammals, ingested ethanol is oxidized to acetaldehyde and then to acetate in the liver;
then, it is converted to acetyl-CoA via ACS (Crabtree et al., 1989; Wolfe, 2005).
Four different reactions that involve the enzymatic production of acetate from acetylCoA have been identified. These reactions can be catalyzed by CoA-transferase, ACH, ACD, or
PTA followed by ACK. All of the corresponding enzymes in these reactions have been identified
in eukaryotes; however, only ADP-forming acetyl-CoA synthetases and acetate:succinate CoAtransferases have been identified in parasites (Tielens et al., 2010).
CoA-transferases are a category of enzymes that catalyze the transfer of a CoA group
from one compound to another and are found in aerobic and anaerobic prokaryotes as well in
many eukaryotes. In parasites, the CoA-transferases involved in acetate production are succinatedependent and are called acetate:succinate CoA-transferases (ASCT, EC 2.8.3.8). Here, acetylCoA transfers its CoA group to succinate, producing acetate and succinyl-CoA (Eq. 18). The
succinyl-CoA formed in this reaction can be converted back into succinate through the action of
succinyl CoA-synthetase (SCS; EC 6.2.1.4/6.2.1.5), an enzyme present in the TCA cycle; this
reaction produces ATP or GTP from ADP or GDP, respectively (Eq. 19). This ASCT/SCS cycle
has been observed in numerous parasites including Tritrichomonas foetus, Trichomonas
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vaginalis (Steinbüchel & Müller, 1986), T. brucei, and two species of Leishmania (Van
Hellemond, Opperdoes, & Tielens, 1998).
Eq. 18: ASCT

Acetyl-CoA + succinate → acetate + succinyl-CoA

Eq. 19: SCS

Succinyl-CoA + Pi + ADP ↔ succinate + CoA + ATP

Acetate can also be produced from acetyl-CoA by simple hydrolysis of the thioester bond
through the action of ACH and acyl-CoA thioesterases (Eq. 20). Interestingly, these reactions do
not conserve the energy in the thioester bond through substrate level phosphorylation once the
bond is hydrolyzed; instead, this energy is released as heat. These enzymes, while not fully
understood, are thought to regulate intracellular levels of CoA esters, the corresponding free
acid, and coenzyme-A (Hunt et al., 2005). Several of these acyl-CoA thioesterases have been
characterized and are thought to participate in acetate production in humans (Hunt & Alexson,
2008) and in the plant Pisum sativum (Zeiher & Randall, 1990). In Saccharomyces, ACH
catalyzes the conversion of acetyl-CoA to acetate (Chen, Zhang, Siewers, & Nielsen, 2015). The
acetate is then transported out of the mitochondria into the cytosol, where it is converted back
into acetyl-CoA by ACS (Chen et al., 2015).
Eq. 20: ACH

Acetyl-CoA + H2O ↔ acetate + CoA

ACD is a member of the NDP-forming acyl-CoA synthetase enzyme superfamily
(Sánchez, Galperin, & Müller, 2000). Originally identified and characterized in the protozoan
parasites Entamoeba histolytica (Jones & Ingram-Smith, 2014; Reeves et al., 1977) and Giardia
lamblia (Donald G. Lindmark, 1980; Sanchez & Müller, 1996), ACD has now been observed in
all three domains of life and catalyzes the reversible conversion of acetyl-CoA, inorganic
phosphate, and ADP into acetate, CoA, and ATP.
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The role of ACD in acetate production was seen first in E. histolytica (Reeves et al.,
1977) and later in Giardia lamblia (Donald G. Lindmark, 1980; Sanchez & Müller, 1996), in
several hyperthermophilic archaea (Musfeldt & Schönheit, 2002; Schäfer & Schönheit, 1991),
and in the rumen anaerobic bacteria Selenomonas ruminantium (Michel & Macy, 1990). While
the physiological role of ACD in E. histolytica is still a topic of debate, the enzyme is thought to
assist the cell in conserving energy through providing additional ATP by way of substrate-level
phosphorylation and CoA recycling (Jones & Ingram-Smith, 2014; Pineda et al., 2016); ACD is
also proposed to allow the cell to utilize acetate for energy by converting it to acetyl-CoA (Jones
& Ingram-Smith, 2014).
ACD is present in a number of other eukaryotic microbes. The enzyme has been
identified and characterized in the bacterium Chloroflexus aurantiacus (Schmidt & Schönheit,
2013), and genes for ACD have been identified in Pelotomaculum thermopropionicum (Kosaka
et al., 2008), Syntrophus aciditrophicus (McInerney et al., 2007), and Propionibacterium
acidipropionici (Parizzi et al., 2012), all of which lack genes for the PTA-ACK pathway. An
ACD homolog gene has also been identified in Plasmodium falciparum (Sánchez et al., 2000).
While it is thought that this parasite uses glucose as its main substrate for energy metabolism, the
process is not well understood at present (Roth, 1990).
Originally, PTA, XFP, and ACK were thought to exist only in prokaryotes; however,
Ingram-Smith et al identified open reading frames for these enzymes in several eukaryotic
microbes (Ingram-Smith, Martin, & Smith, 2006). Both the ACS and PTA-ACK pathways have
been identified in Chlamydomonas and Phytophthora, allowing them to assimilate acetate and
use it as a carbon source or to generate ATP from excess acetyl-CoA in the same manner as does
E. coli (Ingram-Smith et al., 2006). In Chlamydomonas reinhardtii, the genes for PTA and ACK
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are expressed when this algal protist is grown in aerobic cultures; additionally, both proteins are
localized within the mitochondria (Atteia et al., 2006). Chlamydomonas also accumulates acetate
as a major end product in the medium when grown under anoxic conditions (Mus, Dubini,
Seibert, Posewitz, & Grossman, 2007).
The first putative gene sequences for ACK in eukaryotes were identified in Aspergillus
fumigatus and Neurospora crassa and are prevalent in fungi, with three of the four fungal phyla
possessing putative sequences (Ingram-Smith et al., 2006). In fungi and Entamoeba, where PTA
is absent, ACK is likely not used for the activation of acetate; however, in all fungi that possess
ACK, open reading frames encoding XFP were identified. The presence of this enzyme could
allow fungi to produce acetyl-CoA through an XFP-ACK pathway when xylose is available as a
carbon source (Ingram-Smith et al., 2006; Jeffries, 1983). As a sequence for XFP has not been
identified in E. histolytica, this organism is unable to produce acetyl-CoA in the same manner. It
is also possible that the acetate kinase in E. histolytica and fungi is used as part of a different
metabolic or signaling pathway (Ingram-Smith et al., 2006).

Acetate kinase
ACK is a phosphotransferase that catalyzes the reversible conversion of acetyl phosphate
to acetate. ACK was discovered in 1944 in the bacterium Bacillus acidificans longissimus and
kinetically characterized in 1954 (Lipmann, 1944; Rose et al., 1954). While it is most commonly
found in bacteria and archaea, ACK has been identified in several eukaryotic microbes including
fungi, algae, and E. histolytica (Ingram-Smith et al., 2006). At present, two different forms of
ACK have been identified and characterized, one that is ATP-dependent (EC 2.7.2.1) and one,
found only in E. histolytica, that is PPi-dependent (EC 2.7.2.12).
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PPi-ACK
In 1962, the ACK enzyme was first identified in E. histolytica, and it was kinetically
characterized in 1975 (Bragg & Reeves, 1962; Reeves & Guthrie, 1975). In 2006, Ingram-Smith
et al. identified a putative ACK sequence in Entamoeba histolytica. Previously, ACK was seen
only in bacteria with the exception of Methanosarcina thermophila, an archaeon (Ferry, 1997).
ACK activity has been detected in E. histolytica in both cell lysate and recombinant protein
(Fowler, Ingram-Smith, & Smith, 2012; Reeves & Guthrie, 1975).
The ACK of E. histolytica (EhACK) possesses some notable differences from ACKs
found in other organisms. Reeves et al. presented evidence in 1975 showing that, instead of
using ATP/ADP as the phosphoryl donor/acceptor (Eq. 21), EhACK uses inorganic
pyrophosphate/inorganic phosphate (PPi/Pi) to assume these roles (Eq. 22) (Reeves & Guthrie,
1975). They also showed that EhACK departs from the typical kinetic profile of acetate kinases
in that it overwhelmingly favors the acetate-forming direction, with a kcat for the acetate/PPiforming direction being several hundred times higher than that for the acetyl phosphate/Piforming direction (Reeves & Guthrie, 1975). These findings were confirmed by Fowler et al. in
2012, who observed no enzymatic activity in either direction when using ATP/ADP as the
phosphoryl donor/acceptor (Fowler et al., 2012).
Eq. 21: ATP-ACK

acetyl phosphate + ADP ↔ acetate + ATP

Eq. 22: PPi-ACK

acetyl phosphate + Pi → acetate + PPi

Thus far, E. histolytica is the only organism in which a PPi-ACK has been identified.
Considering the observation that two of the enzymes in its glycolytic pathway are PPi-dependent,
it has been hypothesized that one physiological role of this ACK is to provide PPi for completion
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of glycolysis (Figure 1.4) (Fowler et al., 2012). This idea has roots as far back as 1965, when F.
Lipmann suggested that PPi was the first chemical energy currency, being derived from
phosphorus minerals in the environment, and that its high-energy phosphate bonds play a major
role in substrate level phosphorylation(SLP) (Lipmann, 1965); however, there are no known
organisms that utilize environmental PPi or polyphosphates as a source of energy, and research
since Lipmann’s time has shown that the energy in the high-energy organophosphate bonds used
to make ATP in SLP comes from the reaction between reactive carbon compounds and
unreactive phosphate, not vice versa (Martin, 2020). Now, evidence suggests that the most
common function of PPi in metabolism is not to be used in energy metabolism but to be
immediately hydrolyzed following ATP cleavage reactions, thus making the reaction irreversible
under physiological conditions (J. M. Berg, Tymoczko, Gatto, & Stryer, 2015). This, perhaps, is
the reason behind EhACK’s unidirectional reaction mechanism. Some direct experimental
evidence also exists to refute the idea that EhACK plays a role in providing PPi for glycolysis in
E. histolytica. Pineda et al. observed that, in E. histolytica HM-1:IMSS G3 clones, intracellular
levels of PPi fluctuated only marginally in an ACK gene-silenced knockdown when compared to
PPi levels in the wild type. While it seems that the purpose for EhACK’s unique ability to
produce PPi is not to maintain glycolysis, the physiological role of this enzyme remains unclear.
While EhACK has been shown to greatly favor the production of acetate, the source of its
substrate, acetyl phosphate, remains unknown. A gene for PTA has not been found in the E.
histolytica genome, suggesting that the purpose of EhACK is not to activate acetate for
conversion to acetyl-CoA. A gene encoding XFP has also not been detected in E. histolytica. The
absence of these two prominent, acetyl phosphate-generating enzymes in E. histolytica suggests
a novel function for EhACK (Ingram-Smith et al., 2006).
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Figure 1.4. The PPi-dependent glycolytic pathway in E. histolytica. Phosphofructokinase
(PFK) and pyruvate kinase (PK) are replaced with PPi-dependent PFK and pyruvate phosphate
dikinase (PPDK). ACD and the bifunctional aldehyde-alcohol dehydrogenase (ADHE) extend
the glycolytic pathway to produce ethanol (EtOH) and acetate, which can also be produced by
ACK. Figure is modified from Dr. Thanh Dang’s dissertation (Dang, 2017).

32

Aldose Reductase
The aldose reductase (AR) enzymes (EC 1.1.1.21), also known as aldo-keto reductases
(AKRs) or aldehyde reductases, are NAD(P)(H)-dependent oxidoreductases that catalyze the
reduction of carbonyl groups in a wide range of substrates. Most commonly, AR catalyzes the
interconversion between an aldose and an alditol (Eq. 23), although aliphatic and aromatic
aldehydes, ketones, keto prostaglandins, ketosteroids, and xenobiotics have also been shown to
be substrates (Pastel, Pointud, Volat, Martinez, & Lefrançois-Martinez, 2012). AR is of
particular importance in the polyol pathway, an alternate pathway for glucose metabolism that
runs parallel to glycolysis. In the polyol pathway, AR catalyzes the NADPH-dependent
conversion of glucose to sorbitol (Eq. 24), which is then converted to fructose through the action
of sorbitol dehydrogenase (SDH) (Eq. 25). The benefit of this pathway is that it does not require
the input of ATP for energy as glycolysis does; additionally, the polyol pathway results in the
production of NADH, which is used in numerous metabolic processes including glycolysis.
Eq. 23: AR

aldose + NAD(P)(H) ↔ alditol + NAD(P)(+)

Eq. 24: AR

glucose + NADPH → sorbitol + NADP+

Eq. 25: SDH

sorbitol + NAD+ → fructose + NADH

Aldo-keto reductases are grouped into fifteen distinct families based on sequence
identity; these families are labeled AKR1 through AKR15. The members of each family share
less than 40% amino acid sequence identity with the members of other families (Pastel et al.,
2012). More than 150 members of the various families and subfamilies of aldo-keto reductases
have been identified across the prokaryotic and eukaryotic kingdoms (M. Singh, Kapoor, &
Bhatnagar, 2021). AKR1 is divided into five subfamilies, A through E, and of these, AKR1B is
the most studied subfamily (M. Singh et al., 2021). These enzymes are not limited to a single
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location within the various organisms but are expressed in many different cells and tissue types
(Pastel et al., 2012). Open reading frames for putative AR genes have been identified in several
Amoebozoa including E. histolytica, E. dispar, E. invadens, A. castellanii, and M. balamuthi, but
no AR enzymes have been characterized for these organisms.

Structure and mechanism of action
AKRs are monomeric enzymes with a molecular weight between 30 and 40 kDa
(Blakeley et al., 2008; Wilson, Bohren, Gabbay, & Quiocho, 1992). The human protein AKR1B1
consists of 316 amino acid residues folded into β/α-barrel structural motif composed of eight
parallel β strands (Barski, Gabbay, & Bohren, 1999). Eight peripheral α-helical segments
running anti-parallel to the β sheet connect the β strands (Wilson et al., 1992). The enzyme’s
active site is located in the core of the β/α-barrel, and the NADPH cofactor sits atop the barrel,
with the nicotinamide ring extending down into the center of the barrel (Rondeau et al., 1992;
Wilson et al., 1992).
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Figure 1.5. Structure of human protein AKR1B1. The structure of the human aldo-keto
reductase protein AKR1B1 is shown in ribbon view.
Substrate binding to AR during aldehyde reduction is a sequential process. NADPH binds
to the enzyme first, inducing a conformational change that covers a portion of the NADPH with
a surface loop (residues 213-217) (Borhani, Harter, & Petrash, 1992). Once the substrate binds,
the hydride from NADPH transfers to the substrate’s carbonyl carbon, forming the alcohol
product (Borhani et al., 1992). After the alcohol product is released, the enzyme undergoes
another conformational change in which the surface loop moves to uncover NADP+ so that it
may be released (Borhani et al., 1992). Kinetic studies have demonstrated that this second
conformational change represents the rate-limiting step in the reduction of aldehydes (C. E.
Grimshaw, Putney, & Shahbaz, 1990; Charles E. Grimshaw, Bohren, Lai, & Gabbay, 1995;
Kubiseski, Hyndman, Morjana, & Flynn, 1992). Mutagenesis studies of human AR have
identified Tyr-48 as the proton donor to C-4 of the NADPH nicotinamide ring once the hydride
is transferred from this location (Tarle, Borhani, Wilson, Quiocho, & Petrash, 1993). Tyr-48 also
forms a hydrogen-bonding network with Asp-43 and Lys-77, and these residues are essential for
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catalysis (Tarle et al., 1993). Lastly, His-111 was identified as the substrate-binding site (Tarle et
al., 1993).

Physiological significance
AR has been studied most often in humans, where products of the polyol pathway have
been associated with affecting several major physiological functions (M. Singh et al., 2021).
While fructose is important for various functions in the human body, including as a source of
energy in the liver for glycolysis and gluconeogenesis, hyperglycemia has been shown to play a
role in the pathogenesis of several diabetes-related complications such as retinopathy,
nephropathy, neuropathy, and cognitive disorders (Umegaki et al., 2013; Wilson et al., 1992).
Although the mechanism by which hyperglycemia causes tissue damage is not known,
intracellular stress due to accumulation of sorbitol and glycosylation end products has been
shown to be a contributing factor (M. Singh et al., 2021). AR and SDH have been associated
with Type-2 Diabetes Mellitus and related comorbidities in humans (Ohkawa & Kumazawa,
1964; Pottinger, 1967), and AR has been investigated for its potential role as a regulator of
osmolarity under hyperglycemic conditions, with the hypothesis that inhibiting AR could prevent
or manage complications arising from diabetes (Akileshwari et al., 2012; Gabbay & Tze, 1972;
Varma & Kinoshita, 1976).
In addition to its role in diabetes and related complications, AR has also been implicated
in several inflammation-related diseases in humans (M. Singh, Kapoor, & Bhatnagar, 2015). In
one study involving both cellular and animal models, inhibiting AR attenuated the inflammatory
signals caused by cytokines, growth factors, endotoxins, high glucose, allergens, and
autoimmune reactions (M. Singh et al., 2015). Other studies demonstrated that disease outcomes
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in animal models possessing inflammatory diseases such as cardiovascular disease, asthma, and
cancer were significantly improved when aldose reductase was inhibited, indicating that AR
inhibitors may be used as therapeutic interventions for inflammation-related diseases in humans
(S. K. Srivastava et al., 2011).
Some studies, however, have shown that inflammation-induced oxidative stress in
vascular tissue increases upon AR inhibition (S. K. Srivastava, Ramana, & Bhatnagar, 2005),
leading some researchers to assert that AR may have an important role as an antioxidant
(Shinmura et al., 2002; S. K. Srivastava et al., 2005; Tang, Martin, & Hwa, 2012; Thakur, Gupta,
Ali, Singh, & Verma, 2021). AR has been shown to efficiently reduce oxidative stress-generated
lipid aldehydes within the 10-30 micromolar range (Dixit et al., 2000; S. Srivastava, Chandra,
Bhatnagar, Srivastava, & Ansari, 1995).
While the AR-mediated reduction of toxic lipid aldehydes generated by oxidative stress
may immediately appear to be of physiological benefit, numerous studies have shown that the
resulting accumulation of sorbitol resulting from increased expression of AR further creates
oxidative stress in the cell and contributes to development of complications secondary to
diabetes (Dunlop, 2000; Li et al., 2008; Lorenzi, 2007; Oates, 2008; Obrosova, Chung, & Kador,
2010; S. K. Srivastava et al., 2005; SS & SK, 2005). Recent observations suggest that this
increase in oxidative stress may be attributed not to sorbitol accumulation but to changing
NADPH/NADP+ ratios, which could attenuate the glutathione reductase and glutathione
peroxidase systems and increase the ratio of oxidized to reduced glutathione (Puppala et al.,
2012; X. Shi et al., 2012; Thiagarajan, Varsha, Srinivasan, Ravichandran, & Saraboji, 2019).
In light of these findings, AR is thought by many researchers to be best suited for
metabolizing aldehydes generated by lipid peroxidation, with glucose being an incidental
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substrate (M. Singh et al., 2021). As clinical evidence of the benefits of AR inhibition have so far
been mixed and unconvincing, the only AR inhibitor that has been approved for treatment of
secondary diabetic complications in humans is epalrestat, which is designed to treat patients with
diabetic peripheral neuropathy and is sold under the brand name Kinedak® (M. Singh et al.,
2021).
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CHAPTER II
CHARACTERIZATION OF THE ALDOSE REDUCTASE ENZYMES IN ENTAMOEBA
HISTOLYTICA AND INVESTIGATION INTO THEIR PHYSIOLOGICAL ROLES

Abstract
Entamoeba histolytica is an amoebic parasite that lacks the enzymes for the citric acid
cycle and oxidative phosphorylation and relies primarily on glycolysis for ATP production.
During the production of ethanol, one of the two primary end products of glucose metabolism, E.
histolytica consumes two molecules of NADH but produces only one NADH, creating an
imbalance. We investigated aldose reductase (AR) for its role in a potential polyol pathway, an
alternate pathway for glucose metabolism that converts glucose to fructose and results in the
production of NADH. We purified and biochemically characterized two recombinant AR
enzymes, termed EhAR1 and EhAR3. These enzymes act preferentially in the forward sugar
alcohol-forming direction of the reaction and demonstrate activity with a broad range of sugar
and sugar alcohol substrates. Furthermore, EhAR1 and EhAR3 display different oligomeric
states as a monomer and a dimer, respectively. Cell growth was unaffected in an AR1 RNAi cell
line grown at various concentrations of glucose. Activity of sorbitol dehydrogenase (SDH), the
second enzyme in the polyol pathway, was not detected in cell extracts, suggesting that E.
histolytica lacks a functional polyol pathway and that AR serves a different metabolic role as a
glyceraldehyde reductase.
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Introduction
Entamoeba histolytica is an amoebic parasite that is the causative agent of amoebiasis,
infecting an estimated 90 million people worldwide and causing up to 100,000 deaths per year
(Fotedar et al., 2007; World Health Organization, 2007). Infection occurs when the human host
ingests food or water contaminated with fecal matter containing E. histolytica cysts, which enter
the body and colonize in the large intestine by transitioning into the invasive trophozoite form
(World Health Organization, 2007). An amitochondriate, this microaerophilic parasite lacks
many common metabolic pathways such as the citric acid cycle and oxidative phosphorylation
and primarily relies on glycolysis for ATP production (Anderson & Loftus, 2005; Loftus et al.,
2005; Reeves, 1984).
The glycolytic pathway of E. histolytica makes several key departures from the pathway
of the typical eukaryote, one of which is how the pathway proceeds after the production of
pyruvate. In typical eukaryotes, acetyl-CoA produced from pyruvate is transported to the
mitochondria to participate in the citric acid cycle. In E. histolytica, acetyl-CoA produced from
pyruvate is converted to ethanol and acetate as the ultimate products of an extended glycolytic
pathway (Bragg & Reeves, 1962). Ethanol and acetate are produced at a ratio of 2:1 under
anaerobic conditions, whereas in aerobic environments, this ratio is reversed (Montalvo, Reeves,
& Warren, 1971).
The production of ethanol in this extended glycolytic pathway results in a potential
imbalance of NADH. For each molecule of pyruvate produced in glycolysis, one NADH
molecule is produced through the action of glyceraldehyde 3-phosphate (GAPDH); however, for
each molecule of ethanol produced, two molecules of NADH are consumed by the bifunctional
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alcohol/aldehyde dehydrogenase (Lo & Reeves, 1978). Such an imbalance would be presumed to
have a detrimental effect on the cell without a means to correct it.
The polyol pathway was discovered in humans as a means of producing fructose and has
been studied in several organisms for its physiological role in sugar metabolism (Singh, Kapoor,
& Bhatnagar, 2021). An alternative to glucose metabolism by glycolysis, the polyol pathway
consists of two steps: in the first step, AR catalyzes the NADPH-dependent conversion of
glucose to sorbitol (Eq. 1), and in the second step, sorbitol is converted to fructose through the
action of SDH (Eq. 2). Fructose may then re-enter glycolysis. In humans, AR has low affinity for
glucose under normal blood glucose concentration but the polyol pathway becomes active under
hyperglycemic conditions when hexokinase becomes saturated (Brownlee, 2005).
Eq. 1: AR

glucose + NADPH → sorbitol + NADP+

Eq. 2: SDH

sorbitol + NAD+ → fructose + NADH

E. histolytica has three putative genes encoding two distinct AR isozymes, raising the
possibility that an active polyol pathway exists as an alternative to glycolysis for glucose
metabolism. Here, we produced and characterized the two recombinant E. histolytica AR
isozymes. Our results demonstrate that these enzymes, one of which is monomeric and the other
dimeric, use NADPH as an electron donor and strongly prefer the forward, sugar alcoholforming reaction direction of the reaction. Both enzymes are expressed in trophozoites grown on
glucose and AR activity was detected in cell extracts, although we were unable to detect SDH
activity, raising doubt as to the presence of a polyol pathway. Instead, our results suggest that
AR functions as an aldehyde reductase, but its significance in E. histolytica metabolism remains
unknown.
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Methods and materials
Chemicals and reagents
Chemicals were purchased from Qiagen, Promega, Sigma-Aldrich, VWR International,
Gold Biotechnology, Fisher Scientific, Thermo Fisher Scientific, EMD Millipore, Bio-Rad
Laboratories, and Life Technologies. Penicillin-streptomycin solution and Diamond vitamins
purchased from Life Technologies (Carlsbad, CA) and heat-inactivated adult bovine serum from
GeminiBio (Sacramento, CA) were used for Entamoeba media. Restriction enzymes were
purchased from New England Biolabs (Ipswich, MA). Primers were purchased from Integrated
DNA Technologies (Coralville, IA).

Strains and culture conditions
E. histolytica HM-1:IMSS was grown axenically in Diamond’s TYI-S-33 medium
(Diamond, Harlow, & Cunnick, 1978) (17.95 g tryptone, 9.66 g yeast extract, 9.2 g glucose, 1.84
g NaCl, 0.92 g K2HPO4, 1.15 g cysteine, 0.178 g ascorbic acid, 0.0194 g ammonium ferric
chloride, 15% v/v adult bovine serum, 1.73% v/v penicillin-streptomycin, and 2.62% v/v
Diamond vitamins per liter at pH 6.8) at 37°C. Log-phase trophozoites were used for all
experiments. Modifications to media formulations and their designations are as follows: TYI
glucose, standard TYI-S-33 medium as shown above; TYI basal, TYI-S-33 medium without
added glucose; TYI low glucose, TYI-S-33 medium with the glucose reduced to 10 mM.
Growth curves were determined by counting cells every 24 hours using a Luna automated
counter (Logos Biosystem, Annandale, VA). Growth curves were performed with three
biological replicates using trypan blue exclusion (Strober, 2001) to distinguish viable from dead
cells.
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Protein production and purification
Codon-optimized genes for EhAR1 (EHI_029620) and EhAR3 (EHI_178670) were
synthesized and cloned into pET21b by Genscript. This vector provides for an in-frame 6-His tag
for Ni-affinity purification. The recombinant AR enzymes were recombinantly produced in E.
coli Rosetta2(DE3)pLysS. Strains containing the plasmids of interest were grown in LuriaBertani (LB) medium supplemented with 100 μg/mL ampicillin shaking at 250 rpm at 37°C until
an optical density at 600 nm (OD600) of 1.0 was reached. Recombinant protein expression was
induced by the addition of isopropyl-β-D-thiogalactoside (IPTG) to a final concentration of 1
mM. Cells were grown an additional 16-18 hours with continued shaking at 25°C. Bacteria were
harvested by centrifugation at 10,000xg for 15 minutes, and pellets were resuspended in buffer A
(25 mM Tris-HCl, 150 mM NaCl, and 10% glycerol [pH 7.4]) containing 20 mM imidazole. The
cells were disrupted by three passages through a French pressure cell at 40,000 psi. Cell extracts
were centrifuged at 10,000 x g at 4°C for 20 minutes to clarify and the supernatant was
centrifuged again at 40,000 x g for 90 minutes at 4°C.
Recombinant His-tagged AR proteins were purified from the clarified cell extracts by
affinity chromatography using a 5 mL HisTrap HP column (GE Healthcare). Cell extract was
loaded and the column was washed with five column volumes of buffer A containing 20 mM
imidazole. Proteins were then eluted with a linear gradient from 20 mM to 500mM imidazole in
buffer A, and peak protein fractions were collected and dialyzed against buffer A overnight at
4°C. Proteins were aliquoted and stored at -80°C. Protein purity was assessed by SDS-PAGE.
Protein concentration was quantified using the Bio-Rad protein assay (Bio-Rad Laboratories,
Hercules, CA) based on the Bradford dye-binding method (Bradford, 1976). Bovine serum
albumin was used as the standard.
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Quaternary structure determination
To determine the oligomeric states of the recombinant EhAR1 and EhAR3 proteins, size
exclusion chromatography was conducted. The molecular weight standards used were
cytochrome c (12.4 kDa), carbonic anhydrase (29 kDa), bovine serum albumin (66 kDa), βamylase (200 kDa), and blue dextran (2,000 kDa) (Sigma-Aldrich, Inc., St. Louis, MO). The
standards and samples were applied to a Superose 12 HR 10/30 gel filtration column (Amersham
Pharmacia Biotech Limited, Uppsala, Sweden) that was previously equilibrated with buffer
containing 50 mM potassium phosphate (pH 7.0) and 50 mM NaCl. Proteins were separated with
the same buffer at a linear flow rate of 0.5 mL/min. Protein elution was recorded by following
the absorbance signal at 280 nm.

Enzyme assays
AR enzymatic activity was determined spectrophotometrically at 340 nm by monitoring
NADPH oxidation in the sugar alcohol-forming reaction direction or NADP+ reduction in the
sugar-forming direction. Reaction mixtures contained 100mM Tris-HCl at pH 7.0, 1mM
NADPH or NADP+, and purified AR protein were pre-warmed in a 96-well plate to 37°C before
reactions were initiated by addition of the substrate. Reactions were conducted in triplicate to
measure activity. Kinetic parameters Km, kcat, and Vmax were obtained by fitting the data to the
Michaelis-Menten equation by a nonlinear regression calculation using GraphPad Prism 5
(GraphPad Software, San Diego, CA).
E. histolytica cell extracts were assayed for AR activity by harvesting log-phase
trophozoites and resuspending in phosphate-buffered saline (PBS). Cells were lysed using five
rounds of immersion in liquid nitrogen followed by thawing. After lysis, the cell mixtures were
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centrifuged at 10,000xg for five minutes and the clear lysate was collected to use in assays.
Assays were conducted using the above procedure. Reactions lacking cell extract, NADPH, or
sugar substrate, or with heat-killed extract substituted for fresh extract were used as controls.
Cell extracts from log-phase trophozoites were prepared using the above protocol and
assayed for SDH activity using the Sigma Aldrich Sorbitol Dehydrogenase Kit. Reactions were
prepared using the manufacturer’s protocol and sample reactions were conducted in triplicate to
determine mean activity. Reactions lacking cell extract or substrate or with heat-killed extract
substituted for fresh extract were used as controls.

RNAi construct cloning and transfection
The plasmid pKT3M (kindly provided by Dr. Upinder Singh, Stanford University) (Morf,
Pearson, Wang, & Singh, 2013) was used for construction of an AR1 RNAi strain. The fulllength E. histolytica AR (EHI_029620) coding sequence was PCR-amplified from E. histolytica
genomic DNA using KOD hot start polymerase (EMD Millipore, Billerica, MA). The PCR
product was cloned into AvrII and XhoI restriction sites to replace the resident luciferase (LUC)
control gene. The final construct was confirmed by sequencing.
E. histolytica trophozoites were transfected with the AR1 RNAi construct or the control
pKT3M plasmid by electroporation as described previously (Hamann, Nickel, & Tannich, 1995;
Vines et al., 1995). A total of 2.4 x 106 cells were electroporated with 100µg of DNA using two
consecutive pulses at 1.2kV and 25uF and inoculated into TYI-S-33 glucose medium.
Transfectants were selected after two days by adding G418 to a final concentration of 6µg/mL
into the medium. Stable transfectants were maintained under this level of G418 selection.
Primers used for construction of the AR1 RNAi plasmid are listed in Table 2.1.
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Primer Sequences
Cloning primers
EhAR1 RNAi
Forward

5’ TTGCAGCATCAACGCCTAGGAGAAGTTGGAAAAGCAGTAGAGATTG

EhAR1 RNAi

5’ GTTTAAAAAAGAAGAGTTCAACTCGAGTCTTCTTCATCAAGTTC

Reverse

AAAGTCAAA

RT-PCR primers
EhAR1 RTPCR
Forward
EhAR1 RTPCR
Reverse
EhAR3 RTPCR
Forward
EhAR3 RTPCR
Reverse

5’ AAGAGTGCTATAGCAAAGGGGTATGTTAAAA

5’ GGCGCTGGAACTCCTGAACTAATTCC

5’ GAACCATTCTTAAAGAACCACCCTC

5’ ACAATTTTTATCACTTTCATTGGCAGGTTTTCC

ssrRNA Forward

5′-AGGCGCGTAAATTACCCACTTTCG

ssrRNA Reverse

5′-CACCAGACTTGCCCTCCAATTGAT

2.1. Primers used for RNAi construct generation and RT-PCR confirmation

Table 2.1. Primers used for RNAi construct generation and RT-PCR confirmation.

Reverse transcriptase PCR (RT-PCR)
RNA was isolated from 2 x 106 trophozoites using TRIzol (Thermo Fisher Scientific,
Inc., Waltham, MA). Cultured cells were harvested and resuspended in TRIzol, incubated for
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five minutes at room temperature, and centrifuged at 15,000 x g at 4°C for 10 minutes.
Chloroform was added at a ratio of 0.2 mL per mL TRIzol used and the tubes were inverted
repeatedly by hand for 15 seconds to mix the reagents. After incubation at room temperature for
3 minutes, the tubes were centrifuged at 15,000 x g at 4°C for 15 minutes. The colorless top layer
from each tube was transferred to fresh tubes, to which isopropanol was added at a ratio of 0.5
mL per mL TRIzol used to precipitate RNA. Tubes were inverted 3 times to mix the reagents and
incubated at room temperature for 10 minutes. The tubes were centrifuged at 15,000 x g for 10
minutes at room temperature and the supernatant was removed from each tube. The pellets were
rinsed with 1 mL of 75% ethanol and centrifuged at 15,000 x g for 5 minutes at room
temperature. The supernatant was removed from each tube and the pellets were allowed to dry.
Each pellet was resuspended in RNase-free water and stored at -20°C. DNase treatment was
performed on each RNA sample using the Invitrogen TURBO DNA-free kit (Thermo Fisher
Scientific, Inc., Waltham, MA) and the absence of contaminating DNA was determined by PCR.
RT-PCR was employed to determine whether the EhAR1 and EhAR3 genes were
silenced in the AR1 RNAi strain. RT-PCR was performed using the qScript XLT One-Step RTPCR Kit (Qiagen). RNA levels were normalized for comparison using the small subunit
ribosomal RNA gene (accession number: X61116) as previously described (Koushik, Welter,
Rock, & Temesvari, 2014). RT-PCR primers are listed in Table 2.1.

In silico modeling of E. histolytica aldose reductase proteins
The amino acid sequence for each E. histolytica AR protein was used for homology
modeling with SwissModel (Waterhouse et al., 2018; https://swissmodel.expasy.org/). For
EhAR1 and EhAR2, the template used for homology modeling was 6kbl.1.A, the structure of the
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aldo-keto reductase AKR4C14 from Thai Jasmine rice (Oryza sativa L. ssp. Indica)
(Songsiriritthigul, Narawongsanont, Tantitadapitak, Guan, & Chen, 2020). For EhAR3, the
template used for homology modeling was 3h7u.1.A, the crystal structure of the plant stressresponse enzyme AKR4C9 from A. thaliana (Simpson et al., 2009). Templates were selected
based on sequence identity, coverage, Global Model Quality Estimate (GMQE) scores, and
confidence values of predicted catalytic residues. Model quality was assessed in SwissModel
using MolProbity (Chen et al., 2010), and images of models and ligands were generated using
SwissDock (Grosdidier et al., 2011; http://www.swissdock.ch/). Model images were visualized
in UCSF Chimera (Pettersen et al., 2004; https://www.cgl.ucsf.edu/chimera/) and structural
analysis was performed by manual inspection.
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Results
E. histolytica has two distinct aldose reductase isozymes
In E. histolytica, three putative AR genes have been annotated (Loftus et al., 2005) (Table
2.2). Examination of the predicted amino acid sequences for each protein reveals that two
proteins, which we have termed AR1 (EHI_029620) and AR2 (EHI_039190), share 99%
identity, differing only in an isoleucine-to-leucine substitution at position 128. AR3
(EHI_178670), on the other hand, is distinct from AR1 and AR2, sharing 43% identity with the
other proteins. These results show that two distinct AR isozymes exist in E. histolytica. As the
deduced amino acid sequences for AR1 and AR2 are almost completely identical, we
characterized recombinant AR1 and AR3 in this study.
Sequence Identity between Aldose Reductase Proteins
Gene name

Gene ID

Protein Length

AR1

AR2

AR3

Aldose reductase 1

EHI_029620

305 residues

--

99%

43%

Aldose reductase 2

EHI_039190

305 residues

99%

--

43%

Aldose reductase 3

EHI_178670

307 residues

43%

43%

--

2.2. Comparison of E. histolytica aldose reductase predicted protein sequences

Table 2.2. Comparison of E. histolytica aldose reductase predicted protein sequences.
Catalytic residues are conserved in E. histolytica aldose reductase proteins
To identify likely sites of catalysis in E. histolytica AR enzymes, we compared the
predicted amino acid sequences of our AR proteins to that of the aldo-keto reductase AKR1B1
from Homo sapiens, which is perhaps the best-characterized aldo-keto reductase. Mutagenesis
studies in AKR1B1 have identified four amino acid residues essential for catalytic function: Asp43, Tyr-48, Lys-77, and His-111 (Tarle, Borhani, Wilson, Quiocho, & Petrash, 1993). Multiple
sequence alignment (Fig. 2.1) revealed that the E. histolytica AR sequences share 42-47%
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identity with the AKR1B1 amino acid sequence and that the proteins are similar in length, with
AR1 and AR2 being 305 residues long, AR3 being 307 residues long, and AKR1B1 being 316
residues long. Furthermore, all four catalytic residues identified in AKR1B1 are conserved in the
E. histolytica AR proteins.
H. sapiens AKR1B1
E. histolytica AR1
E. histolytica AR2
E. histolytica AR3

:

H. sapiens AKR1B1
E. histolytica AR1
E. histolytica AR2
E. histolytica AR3

: ::::
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:* :***** :

:* :::..*:

*:* :** :*:. *** ****: * **:*:*

. *****:** *
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Figure 2.1. Multiple sequence alignment of aldose reductase proteins. The deduced amino
acid sequences of the AR proteins in E. histolytica were compared with that of the aldo-keto
reductase AKR1B1 from H. sapiens, a well-characterized protein in which the amino acid
residues essential for catalysis have been experimentally identified. These residues are shown in
red outline. Multiple sequence alignment was conducted using Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo/).

Characterization of recombinant E. histolytica AR1 and AR3
Recombinant AR1 and AR3 were produced in E. coli and purified by nickel affinity
chromatography. SDS-PAGE analysis of the purified proteins revealed high purity and that the
subunits for each enzyme were approximately 35 kDa, corresponding well with the calculated
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molecular masses of 36.6 and 37.3 kDa for the AR1 and AR3 recombinant proteins, respectively
(Fig 2.2).

Figure 2.2. Purified recombinant E. histolytica aldose reductases. Proteins were separated by
SDS-PAGE. Marker proteins are shown on the left side of the image, with sizes shown in kDa.
The aldose reductase proteins of E. histolytica display different oligomeric states
To determine the oligomeric states of the AR isozymes in E. histolytica, we subjected the
purified, recombinant AR1 and AR3 proteins to size-exclusion chromatography. The native
molecular mass of AR1 was determined to be 30.5 kDa, consistent with a monomeric structure.
AR3, by contrast, had a native molecular mass of 68.7 kDa, consistent with a dimeric structure;
additionally, AR3 was observed only in the dimeric state. These results suggest that the two
distinct AR isozymes in E. histolytica exist in different oligomeric states.

Kinetic analysis and substrate specificity of aldose reductase proteins
We examined the substrate range of AR1 and AR3 in both the forward, sugar alcoholforming direction of the reaction and the reverse, sugar-forming direction of the reaction. In the
sugar alcohol-forming direction, several of the most biologically relevant aldoses were tested
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using NADPH as the electron donor. Activity was detected with the three-carbon
glyceraldehyde, the five-carbon sugars xylose, ribose, and arabinose, and the six-carbon sugars
glucose, galactose, and mannose (Table 2.3). Both AR1 and AR3 exhibited the highest specific
activity with DL-glyceraldehyde, although the specific activity observed with AR3 was over 10fold higher than that for AR1. Activity was also observed for both enzymes with the six-carbon
ketose fructose; however, the specific activity of AR1 with fructose was 16-fold lower than that
observed for AR3 with this substrate. We examined substrate range for both enzymes in the
reverse, sugar-forming direction of the reaction using NADP as the electron acceptor. Both
enzymes exhibited weak activity in this direction regardless of the sugar alcohol substrate used
(Table 2.4).
Specific Activity
(nmol min-1 mg-1)
AR1
AR3

Substrate
DL-glyceraldehyde
Xylose
Ribose
Arabinose
Glucose
Galactose
Mannose
Fructose

751 ± 28.7
82.7 ± 3.72
20.4 ± 0.38
27.7 ± 0.87
26.3 ± 0.12
62.0 ± 0.78
17.3 ± 0.80
1.79 ± 0.03

8181 ± 405
26.9 ± 0.41
21.7 ± 0.43
6.14 ± 0.27
10.3 ± 0.08
21.1 ± 1.07
10.8 ± 0.40
29.0 ± 0.62

Table 2.3. Specific activities of aldose reductase proteins using sugar substrates. Activities
are the mean ± standard deviation of triplicate reactions. Substrate concentrations used are as
follows: 420 mM DL-glyceraldehyde, 500 mM xylose, 500 mM ribose, 500 mM arabinose, 1 M
glucose, 1 M galactose, 1 M mannose, 1 M fructose. Concentrations were chosen as the one that
exhibited the highest activity.
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Substrate
Glycerol
Xylitol
Arabitol
Sorbitol
Dulcitol
Mannitol

Specific Activity
(nmol min-1 mg-1)
AR1
AR3
0.61 ± 0.03
1.78 ± 0.03
0.20 ± 0.03
5.10 ± 0.02
0.29 ± 0.06
0.42 ± 0.01

2.67 ± 0.09
3.51 ± 0.04
2.86 ± 0.02
0.47 ± 0.03
0.26 ± 0.01
0.48 ± 0.02

Table 2.4. Specific activities of aldose reductase proteins using sugar alcohol substrates.
Activities are the mean ± standard deviation of triplicate reactions. Substrate concentrations used
are as follows: 500 mM glycerol, 500 mM xylitol, 500 mM Arabitol, 500 mM sorbitol, 100 mM
dulcitol, 500 mM mannitol. Concentrations were chosen as the one that exhibited the highest
activity.
Kinetic parameters for AR1 and AR3 were determined using DL-glyceraldehyde as the
substrate (Table 2.5). Determination of kinetic parameters using other substrates was not possible
since enzyme activity was not saturable. Both enzymes displayed Michaelis-Menten kinetics
with this substrate. AR1 exhibited a 2.5-fold lower Km for glyceraldehyde and a 12.7-fold lower
kcat than AR3. Overall, AR3 had a 3-fold higher catalytic efficiency with this substrate.
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Kinetic Parameters with DL-Glyceraldehyde as Substrate
Aldose Reductase 1
Aldose Reductase 3
Km
kcat
kcat/Km
Km
kcat
kcat/Km
-1
-1
-1
-1
(mM)
(s )
(mM s )
(mM)
(s )
(mM-1 s-1)
40.2 ± 0.81
0.50 ± 0.02
0.02 ± 0.01
105 ± 7.17
6.35 ± 0.23
0.06 ± 0.01

Table 2.5. Kinetic parameters of aldose reductase proteins in the presence of DLglyceraldehyde. Parameters were obtained by measuring protein activity with increasing
substrate concentrations and fitting the resulting activity values to the Michaelis-Menten
equation (n=3).

The predicted structures of EhAR1 and EhAR3 are similar to those of characterized aldoketo reductases
To discern the degree to which EhAR1 and EhAR3 are structurally similar to AKRs for
which crystal structures have already been determined, we generated structural models using a
homology-based approach in SwissModel and used UCSC Chimera to visualize and manually
inspect them. The template we selected for EhAR1 was the aldo-keto reductase AKR4C14 from
Thai Jasmine rice (Oryza sativa L. ssp. Indica) based on a Global Model Quality Estimate
(GMQE) of 0.78, coverage of 1.0, and sequence identity of 45.07%. The template we selected
for EhAR3 was the plant stress-response enzyme AKR4C9 from A. thaliana based on a Global
Model Quality Estimate (GMQE) of 0.76, coverage of 0.97, and sequence identity of 38.93%.
Visual comparison of the models with their templates shows structural similarity (Fig.
2.3), with each protein folded into a β/α-barrel structural motif consisting of eight parallel β
strands connected by eight peripheral α-helical segments running anti-parallel to the β sheet. The
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active site for each template and proposed active site for each model lies in the center of the β/αbarrel (Fig. 2.4).

A

B

C

D

Figure 2.3. Structural models of EhAR1 and EhAR3. Structural models of EhAR1 and
EhAR3 proteins and their modeling templates are displayed, with glyceraldehyde shown in stick
view. The structure of the aldo-keto reductase AKR4C14 from Thai Jasmine rice (Oryza sativa
L. ssp. Indica) was used to generate the model for EhAR1, and the structure of the plant stressresponse enzyme AKR4C9 from A. thaliana was used to generate the model for EhAR3. A:
Ribbon view of the O. sativa L. ssp. Indica AKR4C14 protein. B: Ribbon view of EhAR1
model. C: Ribbon view of the A. thaliana AKR4C9 protein. D: Ribbon view of EhAR3 model.
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A

B

Figure 2.4. Active site models of EhAR1 and EhAR3. Space-filling views of the active sites
(A) EhAR1 and (B) EhAR3 protein models and their modeling templates are displayed, with
glyceraldehyde shown in stick view.

Knockdown construction and confirmation
To study the effects of reduced AR expression in E. histolytica, we created an AR1 RNAi
strain using trigger-mediated gene silencing (Morf et al., 2013). AR1 expression was analyzed by
RT-PCR in a control strain transfected with the RNAi vector containing a control gene encoding
luciferase (termed LUC RNAi) and in the AR1 RNAi strain. The absence of contaminating DNA
in the RNA preparations was demonstrated by the inability to PCR amplify constitutively
expressed control gene X61116 encoding a small ribosomal subunit (data not shown).
Our results indicate that the trigger-mediated silencing of AR1 produced a strong
knockdown of AR1 expression (Fig. 2.5). Given the high degree of sequence identity (56%)
between AR1 and AR3, a partial knockdown of AR3 was not unexpected. Indeed, AR3 expression
was reduced in the AR1 RNAi strain but not to the same extent as AR1 expression (Fig. 2.5). It
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should be noted that since AR1 and AR2 are nearly identical at the nucleotide level, RT-PCR
would be expected to detect both transcripts and thus expression of both AR1 and AR2 is
effectively silenced in the AR1 RNAi strain. The small ribosomal subunit gene X61116 was used
as loading control and was unaffected in the AR1 RNAi strain.
LUC AR1

LUC AR1

AR1
Control
(X61116)

AR3
Control
(X61116)

Figure 2.5. Expression of aldose reductase genes in AR1 RNAi cells. RNA was isolated from
the control LUC RNAi strain and the AR1 RNAi strain. Expression of AR1 (left) and AR3 (right)
in AR1 RNAi cells was examined by RT-PCR. Expression of a constitutive control gene
encoding a small ribosomal subunit was used as a loading control.

Using glyceraldehyde as the substrate, we assayed AR enzymatic activity in cell extracts
from the AR1 RNAi strain to determine what effect our knockdown had on overall AR enzyme
activity. Wild type cells displayed a specific activity of 34.5 ± 0.59 nmol min-1 mg-1 and the AR1
RNAi strain displayed a specific activity of 24.1 ± 0.47 nmol min-1 mg-1 in the forward reaction
direction. This represents a 30% reduction in activity in the AR1 RNAi strain compared to wild
type and suggests that AR3 activity is predominant in trophozoites.

SDH activity was not detected in E. histolytica cell extracts
To determine if the polyol pathway is active in E. histolytica, we assayed wild type
trophozoite cell extracts for AR and SDH activity. AR activity in the forward direction with DL76

glyceraldehyde as the substrate was 34.5 ± 0.59 nmol min-1 mg-1. AR activity in the reverse
direction with glycerol as the substrate was only 0.89 ± 0.06 nmol min-1 mg-1, consistent with our
in vitro assays indicating that AR in vivo functions strongly in the forward direction. SDH
activity was not detected in wild type trophozoite cell extracts (Table 2.6).

Specific Activity (nmol min-1 mg-1)

Aldose
reductase
Sorbitol
dehydrogenase

- Extract

Heat-killed
extract

- Substrate

All reagents

ND

ND

ND

34.5 ± 0.59

ND

ND

1.03 ± 0.06

1.03 ± 0.06

Table 2.6. Sorbitol dehydrogenase assay. E. histolytica cell extracts were assayed for SDH
activity in the forward, fructose-producing direction. ND = activity not detected.

Growth was not impacted in AR1 RNAi cells
To examine the effect of reduced expression and activity of aldose reductase on cell
growth, we measured growth of the wild type, LUC RNAi, and AR1 RNAi strains in TYI-S-33
medium containing 50 mM glucose (Fig. 2.6), 10 mM glucose (Fig. 2.7), or no added glucose
(Fig. 2.8). Our results show that cell growth of the AR1 RNAi strain was similar to that of the
LUC RNAi and wild type strains over a 72-hour period in all three types of medium.
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Figure 2.6. Cell growth in TYI glucose medium. E. histolytica log-phase trophozoites from
wild type, LUC RNAi control, and AR RNAi strains were grown in TYI-S-33 medium containing
50 mM glucose and grown at 37°C. Cell counts were taken every 24 hours. Each experiment was
performed with three biological replicates.
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Fig. 2.7. Cell growth in TYI low glucose medium. E. histolytica log-phase trophozoites from
wild type, LUC RNAi control, and AR RNAi strains were grown in TYI-S-33 medium containing
10 mM glucose and grown at 37°C. Cell counts were taken every 24 hours. Each experiment was
performed with three biological replicates.
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Fig. 2.8. Cell growth in TYI basal medium. E. histolytica log-phase trophozoites from wild
type, LUC RNAi control, and AR RNAi strains were grown in TYI-S-33 medium containing no
added glucose and grown at 37°C. Cell counts were taken every 24 hours. Each experiment was
performed with three biological replicates.
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Discussion
Analysis of the predicted amino acid sequences from the three putative aldose reductase
genes in E. histolytica revealed that two proteins, EhAR1 and EhAR2, are nearly identical, while
a third, EhAR3, is distinct from the other two, indicating that E. histolytica produces two
different isozymes for aldose reductase. Given that they share 99% sequence identity, EhAR1
and EhAR2 likely arose by gene duplication. EhAR3 shares 56% identity with EhAR1 and
EhAR2, which may suggest that AR3 performs a function similar to AR1 and AR2 but under
different conditions or that it may perform a function not yet discovered. The presence of
multiple genes in E. histolytica encoding nearly identical enzymes is not unusual and is observed
for both hexokinase and GAPDH. Likewise, other gene sets with two or more nearly identical
genes and one sharing less identity to the others has also been observed, with
phosphofructokinase being an example.
Our kinetic characterization of purified recombinant EhAR1 and EhAR3 proteins
demonstrated that both have AR activity with a broad sugar substrate range. Both were able to
use three- to six-carbon aldoses as substrates as well as the ketose fructose. Glyceraldehyde was
found to be the best substrate, as judged by the high specific activity and high catalytic
efficiency. Both enzymes proved to be unsaturable with other aldose substrates, and the specific
activity with these substrates was much lower than with a similar concentration of
glyceraldehyde.
EhAR3 had over 10-fold higher specific activity and catalytic rate with glyceraldehyde
than EhAR1, although the higher Km reduced the difference in overall catalytic efficiency.
Surprisingly, the oligomeric states of the purified recombinant proteins differed, with EhAR1
being consistent with a monomeric structure EhAR3 being consistent with a dimeric structure.
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The majority of well-characterized AR proteins in other organisms have been reported to exist as
monomers, such as AKR1B1 from H. sapiens (Ruiz et al., 2004) and GRE3 from S. cerevisiae
(Kuhn, Van Zyl, Van Tonder, & Prior, 1995); however, there are some more distantly related
aldo-keto reductase proteins that have been characterized as homodimers, such as AKR7A3 from
Rattus norvegicus (Kelly, Sherratt, Crouch, & Hayes, 2002; Kozma, Brown, Ellis, & Lapthorn,
2002) and Homo sapiens (Debreczeni et al., n.d.), which share 14.6% and 11.4% identity with
EhAR3, respectively. At the amino acid level, EhAR3 shares 43% sequence identity with EhAR1
and EhAR2. It is possible that the differences in oligomeric state between EhAR1 and EhAR3
are a result of these sequence differences.
Multiple sequence alignment of the three E. histolytica AR deduced amino acids
sequences with H. sapiens AKR1B1 revealed that the four amino acid residues essential for
catalysis in the human aldose reductase, Asp-43, Tyr-49, Lys-77, and His-111, are conserved in
all three E. histolytica enzymes and are similarly positioned. Of these, the tyrosine residue at
positions 49/50 is likely the proton donor for NADPH, and the histidine residue at positions
111/110 is likely the substrate-binding site (Borhani, Harter, & Petrash, 1992; Tarle et al., 1993;
Wilson, Bohren, Gabbay, & Quiocho, 1992).
Our analysis of the substrate specificity and kinetic parameters for the AR proteins in E.
histolytica revealed glyceraldehyde as the most effective substrate. One question that arises
concerns the source of glyceraldehyde within the cell. It is possible that glyceraldehyde-3phosphate, an intermediate produced during glycolysis, is also a substrate for one or both AR
enzymes; however, examination of the glycolytic pathway casts doubt on this possibility, as
glyceraldehyde-3-phosphate is used as a substrate in the GAPDH reaction to produce 1,3-
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bisphosphoglycerate and allow glycolysis to proceed. A more likely possibility is that AR
metabolizes other aldehydes produced within the cell.
Examination of the models we generated for EhAR1 and EhAR3 shows that the two
proteins are structurally similar to AKR4C14 from O. sativa L. ssp. Indica and AKR4C9 from A.
thaliana, respectively. Both models share the same β/α-barrel structural motif, with the active
site lying in the middle of the barrel. When glyceraldehyde is positioned within the active site, as
shown in Figure 2.4, the predicted substrate-binding histidine residue at position 111 in EhAR1
and position 110 in EhAR3 lies in close proximity.
The generation of structural models for EhAR1 and EhAR3 also provides some
information on the likely physiological roles of these proteins in E. histolytica. In O. sativa L.
ssp. Indica, AKR4C14 metabolizes methylglyoxal, the reduced derivative of pyruvic acid, and
malondialdehyde, a marker for oxidative stress (Songsiriritthigul et al., 2020). In A. thaliana,
AKR4C9 is thought to reduce toxic aldehydes and ketones produced during stress (Simpson et
al., 2009). Since the modeling templates for both EhAR1 and EhAR3 are both thought to be
involved in the reduction of toxic aldehydes, it is likely that EhAR1 and EhAR3 share a similar
function. This hypothesis is supported by our inability to detect SDH activity in trophozoite cell
extracts, indicating that EhAR1 and EhAR3 do not function as part of a polyol pathway, and our
finding that both proteins displayed the highest activity with glyceraldehyde as substrate.
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Conclusions
Our results demonstrate that E. histolytica possesses at least three genes that encode two
distinct isozymes for aldose reductase. These enzymes act preferentially in the forward sugar
alcohol forming direction of the reaction. Both isozymes have a broad substrate range but kinetic
analysis indicates that glyceraldehyde is the favored substrate. Our results suggest that the E.
histolytica aldose reductases may function in removal of certain aldehydes rather than play a role
in glucose metabolism as part of a polyol pathway.
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CHAPTER III
THE ROLE OF ACETATE KINASE IN THE HUMAN PARASITE
ENTAMOEBA HISTOLYTICA

This work is a continuation of a project begun by Dr. Thanh Dang as part of his doctoral
dissertation under Dr. Ingram-Smith. My contributions were the measurement of intracellular
NAD+/NADH levels, measurement of extracellular ethanol and acetate levels, examination of the
effects of oxidative and nitrosative stress on cell viability, and demonstration of the ability of
GAPDH to metabolize acetaldehyde in the presence of ACK. This chapter is being readied for
submission as a manuscript to a peer-reviewed journal and includes text from Dr. Thanh Dang’s
dissertation (Dang, 2017) to provide the full context of this project. Sections shown in italics
were written by Dr. Dang and are from his dissertation (with some modifications). Figures taken
from Dr. Dang’s dissertation are indicated in the figure legends.

Abstract
Entamoeba histolytica is a human pathogenic parasite that causes approximately 90
million cases of amoebic dysentery, resulting in 50,000-100,000 deaths annually. This
amitochondriate protozoan lacks the enzymes necessary to complete many essential biosynthetic
pathways including the citric acid cycle and oxidative phosphorylation. As a result, glycolysis is
the major source of ATP production. E. histolytica produces ethanol and acetate as its two major
glycolytic end products during growth on glucose. Growth under anaerobic conditions favors
ethanol production by a ratio of 2:1 but also creates an imbalance of NADH. Acetate can be
generated by acetate kinase (EhACK) and ADP-forming acetyl-CoA synthetase (EhACD).
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Uniquely, EhACK produces PPi instead of ATP in its conversion of acetyl phosphate to acetate
and was previously proposed to contribute substantially towards acetate and PPi production.
Here we have investigated the role of ACK in E. histolytica metabolism. Analysis of
intracellular and extracellular metabolites demonstrated that acetate levels were unaffected in an
ACK knockdown strain but acetyl-CoA levels and the NAD+/NADH ratio were significantly
elevated. Moreover, we demonstrated that glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
catalyzes the ACK-dependent conversion of acetaldehyde to acetyl phosphate in E. histolytica.
Thus, we propose that the physiological role of ACK is not as a major contributor to acetate and
PPi production but instead to provide a mechanism for the partitioning of acetyl-CoA between
acetate and ethanol production in the extended glycolytic pathway and for maintaining the
NAD+/NADH balance needed for ethanol production.
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Introduction
Entamoeba histolytica is an amoebic parasite that infects an estimated 90 million people
worldwide and causes approximately 100,000 deaths per year (“CDC: Amebiasis,” n.d.; Haque,
Huston, Hughes, Houpt, & Petri, 2003; Stanley, 2003). Infection proceeds through an oral-fecal
route, resulting in E. histolytica colonization within the large intestine. This amitochondriate
parasite lacks many key metabolic pathways including the citric acid cycle and oxidative
phosphorylation, and glycolysis is the primary pathway for ATP generation (Anderson & Loftus,
2005; Clark et al., 2007; Zuo & Coombs, 1995). Unlike the standard glycolytic pathway, E.
histolytica glycolysis is pyrophosphate (PPi)-dependent. Instead of ATP–dependent
phosphofructokinase and pyruvate kinase, E. histolytica possesses pyrophosphate–dependent
phosphofructokinase (PPi-PFK) and pyruvate phosphate dikinase (PPDK). Pyrophosphate,
therefore, plays an important role in energy conservation.
Ultimately, E. histolytica produces ethanol and acetate as the major end products during
growth on glucose (Bragg & Reeves, 1962). Ethanol is produced by the bifunctional
alcohol/aldehyde dehydrogenase ADHE in a two-step pathway (Bragg & Reeves, 1962). E.
histolytica has two potential acetate-producing enzymes, ACK and ACD (Reeves & Guthrie,
1975; Reeves, Warren, Susskind, & Lo, 1977). ACK is a phosphotransferase that catalyzes the
interconversion of acetyl phosphate and acetate. It is widespread in bacteria where it primarily
functions in a pathway with PTA to activate acetate to acetyl-CoA or produce acetate and ATP
from acetyl-CoA (Kumari, Tishel, Eisenbach, & Wolfe, 1995; Wolfe, 2005). ACK is also present
in the archaeal genus Methanosarcina where it also forms a pathway with PTA for the activation
of acetate as a substrate for methane production (Aceti & Ferry, 1988).
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ACK was previously thought to be absent in eukaryotes but has now been identified in
euascomycete and basidiomycete fungi in which it partners with XFP for the production of
acetate, and in green algae Chlamydomonas reinhardtii and the oomycete Phytophthora in which
it partners with PTA (Ingram-Smith, Martin, & Smith, 2006; Reeves & Guthrie, 1975).
ACK has also been identified in Entamoeba and characterization of recombinant E.
histolytica ACK (EhACK) revealed it to be phosphate/pyrophosphate (PPi)-dependent, a stark
contrast to all other characterized ACKs which are ATP and ADP dependent (Fowler, IngramSmith, & Smith, 2012; Reeves & Guthrie, 1975). EhACK operates primarily in the acetate/PPiproducing direction in vitro (Reeves & Guthrie, 1975). Consistent with this, activity was detected
only in the acetate/PPi-producing direction in cell extract, supporting this as the physiological
direction of EhACK (Fowler et al., 2012). ACK’s role in E. histolytica remains undefined though
and a partner enzyme that produces the acetyl phosphate substrate has not been identified.
Here we investigated the physiological role of ACK in E. histolytica and whether it plays
a role in acetate production during growth on glucose. Our results showed that growth of an ACK
RNAi strain on glucose was unaffected, as were extracellular acetate and ethanol levels as
compared to wild type and control RNAi strains. Intracellular ATP levels were also unaffected
but the ACK RNAi strain had higher intracellular acetyl-CoA as well as an increased
NAD+/NADH ratio. We propose that ACK plays a role in partitioning of acetyl-CoA between
acetate and ethanol production at the end of glycolysis and provides a mechanism for
maintaining proper NAD+/NADH balance during glycolysis and ethanol production.
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Methods and materials
Chemicals and reagents
Chemicals were purchased from Qiagen, Promega, Sigma-Aldrich, VWR International,
Gold Biotechnology, Fisher Scientific, EMD Millipore, and Life Technologies. Penicillinstreptomycin solution and Diamond vitamins purchased from Life Technologies (Carlsbad, CA)
and heat-inactivated adult bovine serum from GeminiBio (Sacramento, CA) were used for
Entamoeba growth media. Restriction enzymes were purchased from New England Biolabs
(Ipswich, MA). Primers were purchased from Integrated DNA Technologies (Coralville, IA).

Strains and culture conditions
E. histolytica HM-1:IMSS was grown axenically at 37°C in Diamond’s TYI-S-33 medium
(Diamond, Harlow, & Cunnick, 1978) (17.95 g tryptone, 9.66 g yeast extract, 9.2 g glucose, 1.84
g NaCl, 0.92 g K2HPO4, 1.15 g cysteine, 0.178 g ascorbic acid, 0.0194 g ammonium ferric
chloride, 15% v/v adult bovine serum, 1.73% v/v penicillin-streptomycin, and 2.62% v/v
Diamond vitamins per liter, final pH 6.8). Trophozoites in log phase growth were used for all
experiments. Modifications to media formulations and their designations are as follows: TYI
glucose, standard TYI-S-33 medium (which contains 50 mM added glucose as shown above);
TYI basal, TYI-S-33 medium without added glucose; TYI low glucose, TYI-S-33 medium with
the glucose reduced to 10 mM. Growth on acetate, propionate, or butyrate was performed in TYI
basal medium supplemented with 63 mM acetate (TYI acetate), 24 mM propionate (TYI
propionate), or 23 mM butyrate (TYI butyrate). These concentrations of short chain fatty acids
represent those found in the large intestine (Cummings, Pomare, Branch, Naylor, & MacFarlane,
1987).
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Growth curves were determined by counting cells every 24 hours using a Luna
Automated counter (Logos Biosystem, Annandale, VA). Trypan blue exclusion (Strober, 2001)
was used to distinguish viable from dead cells. Growth curves were performed with three
biological replicates and values for each time point represent the mean ± standard deviation.

Construct cloning and transfection
The plasmid pKT3M (kindly provided by Dr. Upinder Singh, Stanford University) (Morf,
Pearson, Wang, & Singh, 2013) was used for construction of an ACK RNAi strain. The fulllength Entamoeba histolytica ACK (EHI_170010) coding sequence was PCR-amplified from E.
histolytica genomic DNA using KOD hot start polymerase (EMD Millipore, Billerica, MA). The
PCR product was cloned into AvrII and XhoI restriction sites to replace the resident luciferase
(LUC) control gene. The final construct was confirmed by sequencing.
E. histolytica trophozoites were transfected with the ACK RNAi construct or the control
pKT3M plasmid by electroporation as described previously (Hamann, Nickel, & Tannich, 1995;
Vines et al., 1995). A total of 2.4 x 106 cells were electroporated with 100µg of DNA using two
consecutive pulses at 1.2kV and 25uF and inoculated into TYI-S-33 medium. Transfectants were
selected after two days by adding G418 to a final concentration of 6µg/mL into the medium.
Stable transfectants were maintained under this level of G418 selection. Primers used for
construction of the ACK RNAi plasmid are listed in Table 3.1.
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Primer Sequences
Cloning primers
EhACK RNAi Forward

5’ CTACCTAGGATGTCTAACGTACTAATATTCAACG

EhACK RNAi Reverse

5’ CTACTCGAGTTAAAACTGAAATAATTCTTTTCCTTT TTGTAA

RT-PCR primers
EhACK RTPCR Forward

5’ AGGGTAAATGTTACAGGAACAGA

EhACK RTPCR Reverse

5’ TGGTGCCACACAAACTTGAAC

ssrRNA Forward

5′-AGGCGCGTAAATTACCCACTTTCG

ssrRNA Reverse

5′-CACCAGACTTGCCCTCCAATTGAT

Table 3.1. Primers used for RNAi construct generation and RT-PCR confirmation.

Reverse transcriptase PCR (RT-PCR)
RT-PCR primers are listed in Table 3.1. RNA was isolated from 2 x 106 trophozoites
using the RNeasy mini kit (Qiagen, Valencia, CA) or TRIzol reagent according to the
manufacturers’ instructions. RT-PCR was employed to determine whether the Ehack gene was
silenced in the ACK RNAi strain. RT-PCR was performed using the One-Step RT-PCR kit
(Qiagen). RNA levels were normalized for comparison using the small subunit ribosomal RNA
gene (accession number: X61116) as previously described (Koushik, Welter, Rock, &
Temesvari, 2014).

Enzyme assays
Ehack knockdown was confirmed by measuring ACK activity in cell lysates. A total of 4 x
106 cells were harvested by centrifugation and washed twice in phosphate buffered saline (PBS).
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Cells were resuspended in 25 mM Tris, 150 mM NaCl (pH 7.4) and lysed by vortexing with acidwashed beads for 1 minute, followed by 1 minute on ice. This cycle was repeated three times. The
lysates were centrifuged at 5,000 x g for 15 minutes and the supernatant was retained.
ACK activity was measured using the reverse hydroxamate assay as previously described
(Fowler, Ingram-Smith, & Smith, 2011). Enzyme activity was assessed in a 300 µl reaction
containing 50 mM sodium phosphate, 2 mM acetyl phosphate, 100 mM Tris-HCl (pH 7.0), 10
mM MgCl2, and 50 µl cell lysate at 37oC. Reactions were terminated after 30 minutes by adding
100 µl of the development solution (0.92 M trichloroacetic acid, 250 mM FeCl3, and 2.5 N HCl).
Absorbance at 540 nM was measured using a Synergy Epoch microplate reader (Biotek,
Winooski, VT).
Formation of acetyl phosphate from acetaldehyde by GAPDH was measured in the
presence and absence of ACK. The reaction mix contained 25 mM Tris-HCl (pH 7.0), 2.5 mM
potassium phosphate buffer (pH 7.0), 1 mM NAD+, and 1 mM DTT. Reactions were performed
in the presence or absence of recombinant E. histolytica ACK (EhACK) or Methanosarcina
thermophila ACK (MtACK) (Dang & Ingram-Smith, 2017) as coupling enzyme to convert
acetyl phosphate to acetate to draw the reaction forward. When MtACK was used, 10mM ADP
was also added to the reaction mixture. The reaction was initiated by addition of acetaldehyde to
a final concentration of 500 mM and the absorbance change at 340 nM was measured at 37°C
using a Synergy Epoch microplate reader (Biotek, Winooski, VT) to monitor the conversion of
NAD+ to NADH.
Total protein concentration in cell lysates was measured using the Bradford assay
(Bradford, 1976; Stoscheck, 1990) with bovine serum albumin as the standard.
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Intracellular metabolite analysis
E. histolytica intracellular metabolites were extracted using an adapted methanol
extraction method (Neubauer et al., 2015) from 1 x 106 log phase trophozoites. Cells were
harvested by centrifugation, washed three times in ice cold 5% mannitol solution, and
resuspended in 1.5 ml ice cold 100% methanol. Trophozoites were lysed using three freeze-thaw
cycles in which cells were frozen in liquid nitrogen for 5 minutes and thawed on dry ice for 10
minutes. The lysate was centrifuged at 10,000 x g for 5 minutes and the supernatant isolated.
Samples were analyzed at the Clemson Multi-User Analytic Lab via LC-MS/MS. Intracellular
metabolite concentrations were calculated by assuming E. histolytica trophozoites have an
intracellular volume of 1.3 µl per 1 x 106 cells as previously reported (Pineda et al., 2016;
Scorneaux & Shryock, 1999).

Extracellular metabolite analysis
Acetate in spent TYI glucose medium from 48-hour cultures was measured using the
hydroxamate assay (Fowler et al., 2011). Reaction mixtures containing 100 mM Tris-HCL (pH
7.0), 600 mM hydroxylamine HCl (pH 7.0), 10 mM MgCl2, 10 mM ATP, 100 µg recombinant
MtACK, and 150 µl medium were incubated at 37°C. Reactions were terminated after 30
minutes by adding 600 µl of the development solution (0.92 M trichloroacetic acid, 250 mM
FeCl3, and 2 N HCl). Samples were centrifuged at 10,000 x g for 5 minutes to pellet precipitated
proteins. The absorbance at 540 nM was measured using a Synergy Epoch microplate reader
(Biotek, Winooski, VT) and compared against a standard curve.
Ethanol in spent TYI glucose medium from 48-hour cultures was measured using the
EnzyChrom™ Ethanol Assay Kit (BioAssay Systems, Hayward, CA), which is based on the
alcohol dehydrogenase-catalyzed oxidation of ethanol. Reactions were prepared according to the
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manufacturer's instructions and terminated after 30 minutes. Absorbance at 565 nM was
measured using a Synergy Epoch microplate reader (Biotek, Winooski, VT). A minimum of four
biological replicates was used for ethanol and acetate determinations.

Oxidative stress and nitrosative stress induction
The effect of oxidative or nitrosative stress on E. histolytica trophozoites was determined
by exposing trophozoites to hydrogen peroxide or sodium nitroprusside in liquid culture and then
assessing change in cell viability. Log-phase trophozoites were harvested and counted using
trypan blue exclusion (Strober, 2001) on a Luna Automated Counter (Logos Biosystem,
Annandale, VA). Samples containing 3.5x104 live cells resuspended in fresh, prewarmed TYI
glucose medium were prepared for each culture. For oxidative stress, hydrogen peroxide was
added to final concentration of 5 mM to one sample and an equal volume of water was added to
the control sample. For nitrosative stress, sodium nitroprusside was added to a final
concentration of 5 mM to one sample and an equal volume of water was added to the control
sample. Sample tubes were rotated for 3 hours at 37°C, and cell viability was determine using
trypan blue exclusion. The difference in cell viability between each sample and its control was
recorded to determine the effect of oxidative or nitrosative stress on each cell type. Three
biological replicates were performed for each cell type.
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Results
Trigger-mediated ACK gene silencing
To investigate the role of ACK in E. histolytica, we created an ACK RNAi strain to
examine the effect of ACK gene silencing on growth. The ACK gene was silenced using the
trigger-mediated small antisense gene silencing method developed by Morf et al. (Morf et al.,
2013). The ACK coding sequence was cloned into the pKT3M vector to replace the control
luciferase gene (LUC) and transfected into wild type E. histolytica. An RNAi control strain was
also constructed using pKT3M harboring the LUC gene. RT-PCR was performed to examine
ACK transcript levels in wild type, the LUC RNAi strain, and the ACK RNAi strain. ACK mRNA
levels were undetectable in the ACK RNAi strain but were unaffected in the LUC RNAi strain as
compared to wild type (Fig. 3.1). Enzymatic assays demonstrated that ACK enzymatic activity
was reduced 18-fold in the ACK RNAi strain but was unaffected in the control LUC RNAi strain
(Fig. 3.2). Taken together, these results confirmed successful ACK silencing.

ACK is dispensable for growth on glucose
Since acetate and ethanol are both produced during growth on glucose (Bragg & Reeves,
1962) and ACK is one possible route for production of acetate, we examined whether growth on
glucose was impaired in the ACK RNAi strain. We examined growth in standard TYI-S-33
medium, which contains 50 mM added glucose (and is designated here as TYI glucose), and in
TYI-S-33 medium in which the added glucose has been lowered to 10 mM (designated here as
TYI low glucose). Growth of the ACK RNAi strain was comparable to that of the LUC RNAi
strain and the wild type strain at both glucose levels (Fig. 3.3).
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Figure 3.1. Expression of ACK in EhACK RNAi cells. RNA was isolated from wild type cells,
the EhACK RNAi strain, and the control LUC RNAi strain. Expression of EhACK (top) was
examined by RT-PCR. Expression of a constitutive control gene encoding a small ribosomal
subunit was used as a loading control (bottom). Figure is modified from Dr. Thanh Dang’s
dissertation (Dang, 2017).

Figure 3.2. ACK activity in EhACK RNAi cells. Acetate kinase activity in the acetate-forming
direction was measured using the reverse hydroxamate assay. Activities are the mean ± standard
deviation of three replicates. All specific activities are normalized to that observed for extracts
from the wild type strain, represented as 100%. Figure is modified from Dr. Thanh Dang’s
dissertation (Dang, 2017).
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A

B

Figure 3.3. Growth of ACK RNAi cells in various glucose concentrations. Growth of EhACK
RNAi cells in (A) TYI glucose medium, and (B) TYI low glucose medium was measured using
trypan blue exclusion. Cell counts are the mean ± standard deviation of three biological
replicates. Figure is modified from Dr. Thanh Dang’s dissertation (Dang, 2017).
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Intracellular but not extracellular metabolite levels are altered in the ACK RNAi strain
We determined intracellular acetyl-CoA and ATP levels in cells grown for 48 hours in
TYI glucose medium as measures of glycolytic activity and intracellular energy levels. The ACK
RNAi strain showed an accumulation of acetyl-CoA, with a level ~172% that of the wild type
and LUC RNAi strains, but the intracellular ATP level was unaffected (Fig. 3.4A). The ACK
RNAi strain also experienced an increased NAD+/NADH ratio ~2.5-fold higher than that
observed for the LUC RNAi strain and ~4.9-fold higher than for the wild type strain (Fig. 3.4B).
This difference in NAD+/NADH ratio was due primarily to a reduced NADH level in the ACK
RNAi strain. Intracellular NAD+ was similar in all three strains, with the LUC RNAi and ACK
RNAi strains exhibiting NAD+ levels 130.7  7.9 and 113.5  15.4% that of the wild type strain,
respectively. Intracellular NADH was reduced in the both the LUC RNAi and ACK RNAi strain
to 56.3  25.0% and 21.9  0.3% that of the wild type, respectively. Therefore, it appears that
G418 selection of the two RNAi strains may have an impact on intracellular NADH levels.
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Figure 3.4. Intracellular metabolite levels in ACK RNAi cells. Metabolites were extracted
using methanol extraction from log-phase trophozoites and concentrations were measured using
LC-MS/MS. (A) Concentrations of acetyl-CoA and ATP. Figure is modified from Dr. Thanh
Dang’s dissertation (Dang, 2017). (B) Ratio of NAD+/NADH, normalized to wild type ratio.
Measurements are the mean ± standard deviation of three replicates (**p<.01, ***p<.001).

E. histolytica produces extracellular ethanol and acetate during growth on glucose, with
the ratio varying depending on whether growth is under aerobic or anaerobic conditions
(Montalvo, Reeves, & Warren, 1971). To determine if ACK plays a significant role in production
of acetate and the ethanol:acetate ratio, we measured extracellular acetate and ethanol in spent
medium from the wild type, LUC RNAi, and ACK RNAi strains grown for 48 hours in TYI
glucose medium. Production of acetate and ethanol was similar in the ACK RNAi strain versus
the wild type strain or the LUC RNAi control strain (Fig. 3.5), and the calculated ratios of
ethanol to acetate were found to be 1.8:1, 1.7:1, and 1.6:1 for the wild type, LUC RNAi, and
ACK RNA strains, respectively.
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Ethanol
Acetate

Figure 3.5. Extracellular ethanol and acetate levels in spent TYI glucose medium. Ethanol
and acetate levels were measured in spent medium from cultures of wild type, LUC RNAi, and
ACK RNAi strains grown in TYI glucose medium for 48 hours. The results shown represent the
mean ± standard deviation for four to five biological replicates for each strain. Unpaired t-test
revealed no statistical difference between strains for either ethanol or acetate.

ACK does not play a role in utilization of short chain fatty acids
The human colon, where E. histolytica colonizes, is a glucose-poor environment as most
dietary glucose is absorbed in the small intestine. Short chain fatty acids (SCFAs) are abundant
though with a total concentration of 110-120 mM mainly as acetate, propionate, and butyrate
with a relative molar mass ratio of 57:22:21, respectively (Cummings et al., 1987). Although
kinetic analysis of the E. histolytica ACK has shown it functions strongly in the direction of
acetate production rather than acetate utilization (Dang & Ingram-Smith, 2017; Fowler et al.,
2012), we examined whether growth of the ACK RNAi strain was impaired in the presence of
SCFAs. Wild type, LUC RNAi, and ACK RNAi strains were grown in TYI-S-33 medium lacking
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added glucose (designated as TYI basal medium) or TYI basal medium supplemented with 63
mM acetate, 24 mM propionate, or 23 mM butyrate (final concentration) for 72 hours. These
concentrations represent the estimated concentrations found in the colon based on total SCFA
abundance and relative molar ratios. Growth of the ACK RNAi strain was similar to that the wild
type and LUC RNAi strains for all four media (Fig. 3.6). Interestingly, all three strains showed
slightly enhanced growth in the presence of added propionate versus TYI basal medium but the
presence of acetate or butyrate had no effect.
WT
LUC
EhACK

Figure 3.6. Growth of EhACK RNAi cells in medium supplemented with short-chain fatty
acids. Wild type (WT), LUC RNAi (LUC), and EhACK RNAi (EhACK) cells were grown for 72
hours in TYI basal medium or TYI basal medium supplemented with a short-chain fatty acid
(SCFA). SCFAs are Ac: acetate; Prop: propionate; But: butyrate. Cell counts are the mean ±
standard deviation of three biological replicates. Figure is modified from Dr. Thanh Dang’s
dissertation (Dang, 2017).
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Oxidative and nitrosative stress response are unaffected in the ACK RNAi strain
We examined the effect of oxidative stress on an ACK RNAi strain by exposing logphase trophozoites to oxidative stress from exposure to hydrogen peroxide. Cells were grown in
TYI glucose or TYI basal medium and exposed to 5 mM hydrogen peroxide (final concentration)
for 3 hours and the change in viability was measured. The ACK RNAi strain displayed similar
changes in viability due to oxidative stress as the wild type and LUC RNAi control strains (Fig.
3.7A). When grown on TYI glucose medium, all three strains showed 40-45% reduced viability
after hydrogen peroxide exposure versus mock treated control cells. When grown on TYI basal
medium though, the strains had only 18-20% reduced viability after hydrogen peroxide exposure
versus mock treated control cells. All three strains showed a statistically significant difference in
viability reduction in response to oxidative stress when grown on TYI glucose medium
compared to growth on TYI basal medium.
To examine the effect of nitrosative stress on ACK RNAi cells, we exposed trophozoites
grown in TYI glucose and TYI basal medium to 5 mM sodium nitroprusside (final
concentration) and determined the change in viability after three hours in treated versus mock
treated samples. All three strains were similarly affected by nitrosative stress. Viability was
reduced 18-19% in all three strains when grown on TYI glucose medium and 13-15% when
grown in TYI basal medium (Fig. 3.7B).
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Figure 3.7: Effects of oxidative and nitrosative stress on ACK RNAi cells. Log-phase
trophozoites in liquid medium were exposed to (A) 5 mM hydrogen peroxide (final
concentration) for three hours at 37°C to examine the effects of oxidative stress or to (B) 5 mM
sodium nitroprusside (final concentration) for three hours at 37°C to examine the effects of
nitrosative stress. Viability was determined using trypan blue exclusion. Values shown are the
mean ± SD of three biological replicates. Unpaired t-test showed statistically significant
difference in viability reduction in response to oxidative stress when grown on TYI glucose
medium compared to growth on TYI basal medium (*p<.05, ***p<.001).

E. histolytica GAPDH displays acetyl phosphate-forming activity in the presence of ACK
Although ACK activity has been detected in E. histolytica cell extracts (Fowler et al.,
2012), the source of the acetyl phosphate substrate has remained unknown as the typical partner
enzymes PTA and XFP are absent in E. histolytica. In 1954, Harting and Velick (Harting &
Velick, 1954) demonstrated that rabbit muscle and yeast GAPDH can catalyze the
phosphorylation acetaldehyde to form acetyl phosphate. This enzyme is typically used to
catalyze the phosphorylation of glyceraldehyde 3-phosphate to 1,3-bisphosphoglycerate in an
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NAD+-dependent reaction as part of glycolysis. E. histolytica has three nearly identical genes
encoding GAPDH.
We tested whether recombinant E. histolytica GAPDH was also able to produce acetyl
phosphate from acetaldehyde. We demonstrated that the purified recombinant E. histolytica
GAPDH was active with glyceraldehyde 3-phosphate (Jin Cho, personal communication);
however, no activity was detectable with acetaldehyde as the substrate. We next tested GAPDH
activity with acetaldehyde in the presence of ACK as this might draw the reaction in the
direction of acetyl phosphate production. E. histolytica ACK shows strong activity in the
direction of acetate formation using Pi and acetyl phosphate as substrates, whereas the
Methanosarcina thermophila ACK is active in both directions of the reaction and uses ADP
instead of Pi (Aceti & Ferry, 1988). The coupled GAPDH-ACK reactions would be expected to
proceed as follows:
1. acetaldehyde + Pi + NAD+ → acetyl phosphate + NADH

GAPDH

2. acetyl phosphate + Pi/ADP → acetate + PPi/ATP

ACK

When GAPDH activity with acetaldehyde was measured in the presence of ACK,
conversion of NAD+ to NADH was detected (Table 3.2). The specific activity of E. histolytica
GAPDH with acetaldehyde was 14.1 ± 0.60 nmol min-1 mg-1 in the presence of EhACK. A
specific activity of 128 ± 2.33 nmol min-1 mg-1 was observed in the presence of MtACK and
activity was ADP-dependent.

108

Specific Activity (nmol min-1 mg-1)
+ 2.5 mM Pi

+ 10 mM ADP, + 2.5 mM Pi

ND

ND

GAPDH + EhACK

14.1 ± 0.60

7.04 ± 0.90

GAPDH + MtACK

2.29 ± 0.16

128 ± 2.33

GAPDH

Table 3.2. Specific activity of GAPDH with acetaldehyde as substrate. The specific activity
of purified GAPDH was measured in the absence and presence of ACKs from E. histolytica and
M. thermophila using acetaldehyde as the substrate. Activity was detected only in the presence of
ACK. When MtACK was present, activity was ADP-dependent. Values shown are the mean ±
SD of three biological replicates. ND = activity not detected.
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Discussion
EhACK has been hypothesized to provide supplemental pyrophosphate for the
pyrophosphate-dependent glycolysis in E. histolytica . In a comparison between the
transcriptome of the virulent HM–1:IMSS and the nonvirulent Rahman strains, several glycolytic
enzymes including PPi–PFK were found to be highly upregulated in HM–1:IMSS in both axenic
culture and during contact with human colon explant (Thibeaux et al., 2013). This upregulation
was thought to reflect the carbon metabolism needs during colonic mucosa degradation and
tissue destruction during intestinal amoebiasis. EhACK is constitutively expressed in active
trophozoites and at a slightly higher level in HM–1:IMSS versus the Rahman strain
(Ehrenkaufer, Haque, Hackney, Eichinger, & Singh, 2007; Hon et al., 2013). These findings
supported the possibility that EhACK could work in unison with PPi–PFK and PPDK to drive
glycolysis, although the source of the acetyl phosphate substrate for ACK was unknown.
Here we used RNAi gene silencing to investigate the role of ACK in E. histolytica
metabolism. As acetate and ethanol are the two primary end products of glucose breakdown, we
hypothesized that if ACK’s primary role is production of acetate and PPi, then growth on glucose
would be affected in an ACK RNAi strain. This was not the case though, as growth on low and
high glucose concentrations was similar for the ACK RNAi strain and the control LUC RNAi and
wild type strains. Measurements of extracellular acetate and ethanol levels revealed no difference
between the three strains either. These results suggest that ACK is not a major contributor to
acetate production, and thus not PPi production, at least not during standard growth on glucose as
the main carbon and energy source.
E. histolytica produces both ethanol and acetate as the primary products of glucose
metabolism. These are produced as part of an extended glycolytic pathway in which pyruvate is
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first converted to acetyl-CoA, which is then broken down to acetate and ethanol by ADPforming acetyl-CoA synthetase (ACD) and alcohol dehydrogenase (ADHE), respectively.
Ethanol production by ADHE consumes more NADH than is produced by glycolysis. Glycolysis
generates one NADH molecule per pyruvate produced; however, two NADH are required per
ethanol produced from pyruvate, one for each step of the two-step ADHE reaction. This
imbalance would exist except when the ratio of ethanol to acetate production is 1:1. We observed
a ratio closer to 2:1 ethanol:acetate, similar to previously published values (Montalvo et al.,
1971), suggesting that such an imbalance would be present.
We propose that ACK plays a role in the extended glycolytic pathway in maintaining the
proper NAD+/NADH ratio during growth on glucose. In this proposed pathway, shown in Fig.
3.8, when NADH levels are insufficient to continue ethanol production acetaldehyde produced in
the first step of the ADHE reaction would be released to GAPDH, which would then convert it to
acetyl phosphate for use by ACK (Harting & Velick, 1954). NADH would be generated in this
process. This would be expected to be an overflow pathway that would not be a major
contributor to acetate production.
Consistent with this proposed pathway, we showed that GAPDH can indeed use
acetaldehyde as a substrate but only when ACK was present to draw the reaction toward acetyl
phosphate production. Conversion of NAD+ to NADH, indicating GAPDH activity, was
observed when both EhACK and MtACK were included in the reaction mixture. In the presence
of MtACK, activity was ADP-dependent as expected. We also observed that an ACK RNAi
strain has increased intracellular acetyl-CoA, suggesting that the inability to shunt acetaldehyde
into a GAPDH-ACK pathway causes a slowdown of the ADHE pathway.
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Figure 3.8. Proposed model of the extended glycolytic pathway in E. histolytica.
Abbreviations are as follows: PFOR: pyruvate:ferredoxin oxidoreductase; ADHE:
alcohol/aldehyde dehydrogenase; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; ACK:
acetate kinase; ACD: acetyl-CoA synthetase (ADP-forming).

We induced oxidative and nitrosative stress in E. histolytica trophozoites to observe the
effect that reduced ACK activity would have on cell viability under variable glucose conditions.
We observed that induction of oxidative stress negatively had a greater effect on the reduction in
viability in the presence of glucose compared to the absence of glucose for all three cell lines.
This indicates that E. histolytica better tolerates oxidative stress when glycolysis is less active.
Reduction in ACK activity did not confer an advantage or disadvantage for oxidative stress
tolerance. Given that ACK does not seem to be a major contributor to PPi production and cell
growth, this result is not unexpected. Our data is also consistent with previous research that
showed ACK was not significantly differentially expressed in cells exposed to oxidative stress
(Vicente, Ehrenkaufer, Saraiva, Teixeira, & Singh, 2009). Reduction in ACK activity did not
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confer an advantage or disadvantage for nitrosative stress tolerance either; however, ACK RNAi
cells tolerated nitrosative stress better in the absence of glucose than in glucose-containing
medium. The reason for this is not known and should be investigated further. Since ACK affects
intracellular acetyl-CoA and NAD+/NADH levels, studying the effects of oxidative stress on
glycolytic metabolite concentrations, cell viability, and ability of cells to recover from stress over
longer periods of time may also be of interest.
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Conclusions
Our results suggest that, contrary to our starting hypothesis, ACK is unlikely to be a
major contributor to acetate production or the PPi pool in E. histolytica. We have demonstrated
that reduction in ACK activity affects intracellular acetyl-CoA levels and the NAD+/NADH
ratio. Furthermore, we showed that E. histolytica GAPDH catalyzes the conversion of
acetaldehyde to acetyl phosphate in the presence but not absence of ACK. These results suggest
that ACK plays a role in the extended glycolytic pathway in E. histolytica in partitioning of
acetyl-CoA between acetate and ethanol production and providing a mechanism for maintaining
proper NAD+/NADH balance during glycolysis and ethanol production.
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CHAPTER IV
CONCLUSIONS AND FUTURE DIRECTIONS

Characterization and physiological role of aldose reductase
Our initial interest in aldose reductase was the possibility that E. histolytica had a
functional polyol pathway. The polyol pathway is important in humans in its relation to diabetes.
Our initial hypothesis was that E. histolytica AR acted as part of a polyol pathway as an alternate
glucose metabolism pathway to relieve overload of glycolysis at high glucose concentrations and
to produce NADH to resolve an imbalance that may occur when ethanol production
predominates over acetate production. The end product fructose could then re-enter glycolysis as
needed.
Our characterization of AR showed that E. histolytica possesses two distinct isozymes,
EhAR1 and EhAR3, that catalyze the conversion of glyceraldehyde into glycerol. While EhAR1
and EhAR3 both perform this function, they do so with different catalytic efficiencies. Our
finding that glyceraldehyde is the favored substrate and that SDH activity was not detected in
cell extracts argues against our original hypothesis. Although EhAR1 and EhAR3 can utilize a
broad range of sugars as substrate, it is possible that the enzymes perform a function different
from this and that their ability to metabolize aldoses and ketoses is incidental.
Future avenues for this research would be to examine AR’s ability to act as an aldehyde
reductase. The aldehyde substrate range and preference may suggest potential roles for this
enzyme in E. histolytica physiology. One possible role would be for detoxification of chemically
reactive aldehydes, which can be toxic. Aldehydes are abundant in the human intestinal tract, and
a total of 34 aldehydes were detected in human feces in one study (Wishart et al., 2018).
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Aldehydes are produced by gut bacteria and are present in many foods (Ameur et al., 2006;
Guillén et al., n.d.; Kus et al., 2007; Mu et al., 2018; O’Brien & Morrissey, 1989; Peng et al.,
2017; Pérez-Burillo et al., 2018; Schwab et al., 2017; Shetty et al., 2018).
If AR’s role is not to broadly metabolize aldehydes but is instead more specific to
glyceraldehyde, it is important to investigate the key source(s) of glyceraldehyde in order to
understand what metabolic processes are involved. It would also be useful to examine the role of
the glycerol product of the reaction, as glycerol biosynthesis has been associated with oxidative
stress induction in E. histolytica (Husain et al., 2012). The possibility that AR is involved in this
process should be investigated further.

Physiological role of acetate kinase
We began our investigation of the E. histolytica acetate kinase with the hypothesis that,
since its conversion of acetyl phosphate to acetate produces PPi and not ATP as in typical ACKs,
it has a significant role in acetate production and in providing PPi for the organism’s PPidependent glycolytic pathway. However, our experimental data did not support this hypothesis.
Extracellular acetate levels and growth on both low- and high-glucose concentrations were
unaffected in an ACK RNAi cell line, so it is unlikely that ACK is a major contributor to acetate
production or the PPi pool in E. histolytica.
Metabolomics analysis showed that acetyl-CoA levels and the NAD+/NADH ratio were
significantly elevated in ACK RNAi cells. This led us to hypothesize that ACK is involved in the
E. histolytica’s extended glycolytic pathway by which glucose is metabolized to acetate and
ethanol. The source of ACK’s acetyl phosphate substrate, however, remained a mystery. In 1954,
Harting and Velick demonstrated that GAPDH catalyzes the conversion of acetaldehyde to acetyl
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phosphate in rabbit muscle and yeast cells (Harting & Velick, 1954). We tested this reaction in
vitro and demonstrated that recombinant E. histolytica GAPDH displays acetyl phosphateforming activity in the presence but not absence of ACK. This result indicates that the GAPDHcatalyzed conversion of acetaldehyde into acetyl phosphate is a source of substrate for ACK in E.
histolytica.
Our results are consistent with ACK playing a role in the extended glycolytic pathway in
E. histolytica in partitioning of acetyl-CoA between acetate and ethanol production and
providing a mechanism for maintaining proper NAD+/NADH balance during glycolysis and
ethanol production.

Final thoughts
To sum up, we have investigated two pathways proposed to play a role in glucose
metabolism and maintenance of the intracellular NAD+/NADH balance needed for completion of
glycolysis under anaerobic conditions. Our results demonstrate that ACK fulfills this role. AR,
which we originally hypothesized to be part of a polyol pathway, appears instead to play a role in
metabolism of aldehydes, and as such may provide a protective mechanism against aldehydes
present in the human intestinal tract.
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